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Abstract 
Alpha-1 antitrypsin deficiency, for which there is no cure, is one of the most lethal 
genetic diseases among the European White population.  Early and proper diagnosis is 
challenging, as understanding how both alpha-1 antitrypsin deficient patients and their 
family caregivers cope with their related stressors on a daily basis.  This qualitative 
phenomenological study incorporated the biopsychosocial approach, the Bowen family 
systems theory, and the family systems model of illness to examine the experiences of 
Alpha-1 patients and their family caregivers related to living with the disease and coping 
strategies.  Participants were recruited with the assistance of a national organization that 
serves the study population.  Sixteen participants, (8 alpha-1 deficient individuals and 8 
primary family caregivers) were interviewed.  Data were analyzed to identify codes and 
resulting themes. The data analysis led to the identification to the following themes: (a) 
shock; (b) misdiagnosis; (c) lack of awareness; (d) lengthy multiple medical evaluations 
necessary to be appropriately diagnosed; (e) caregiver shock; (f) caregiver despair in 
watching their loved ones struggle; and (g) keeping busy and a positive family dynamic  
because  factors  help the participants cope with the challenges of alpha on a daily basis.  
The results provide an understanding of the complexities of alpha-1 deficiency and how it 
impacts the lives of alpha-1 deficient participants and their family caregivers.  This 
information might be used by alpha-1 community members and health care practitioners 
to bring about social change by creating additional resources needed to improve 
communication between the health care system and alpha-1 community, as well as assist 
alpha-1 patients and caregivers in managing the disease. 
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Chapter 1: Introduction to the Study 
Chronic obstructive pulmonary disease (COPD) is an umbrella term used to 
describe progressive lung disease including emphysema, chronic bronchitis, asthma, and 
some forms of bronchiectasis (COPD Foundation, 2017).  Alpha-1 antitrypsin deficiency 
(AAT-D) is a relatively common genetic disorder that is related to COPD and caused by 
a deficiency of the alpha-1 protein in the bloodstream (COPD Foundation, 2017).  People 
with AAT-D, which is often misdiagnosed are predisposed to COPD and liver disease, 
researchers have found that without the alpha-1 protein, white blood cells begin to harm 
the lungs and lung deterioration occurs (Anariba, 2017).  AAT-D is a deficiency 
characterized by the development of COPD and/or liver damage in adults between the 
ages of 20 to 50 years old or liver disease in children (Anariba, 2017).  Individuals will 
not know that they have the disease unless their doctor recognizes the specific signs and 
symptoms and asks for the designed blood examination which directly tests for the AAT-
D (Alpha-1 Association, 2015).  The challenges faced by patients in receiving proper 
diagnosis not only affect AAT-D patients but also their family caregivers.   
Furthermore, the daily challenges involved in caring for AAT-D individuals place 
strains on caregivers’ physical and/or emotional well-being, social lives, and financial 
situations (Lee, Lum, Xiang, Ungvari, & Tang, 2010).  In the present study I examined 
the complexity and challenges both AAT-D patients and their family caregivers 
encounter daily and the most common coping methods used to best manage their 
stressors.  In Chapter 2, I further discuss how I drew from biopsychosocial model (1977), 
Bowen’s (1974) family systems theory and the family systems model of illness (Rolland, 
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Emmanuel, & Torke, 2017) to elicit a deeper insight into the experiences AAT-D patients 
and their family caregivers. 
Background 
Alpha-1 antitrypsin is a protein that is normally found in the lungs and 
bloodstream and which helps protect the liver and lungs from outside toxins and hazards 
as well as from diseases, such as cirrhosis, emphysema, and chronic COPD (de Serres, 
Bianco, & Fernandez, 2003).  AAT-D is one of the three most common lethal genetic 
diseases among adult European White, affecting one out of 3,000 to 5,000 individuals ( 
Anariba, 2017).  Severe AAT-D affects an estimated 70,000 to 100,000 individuals in the 
United States with approximately 25 million people carrying at least one deficient gene 
(Anariba, 2017).  World- wide, European White constitute approximately 117 million 
carriers, and 3.4 million are affected (Anariba, 2017).  Although AAT-D is most 
commonly found in individuals of Northern European and Iberian descent, it has been 
identified in all populations (Anariba, 2017). 
Common symptoms of AAT-D are reoccurring upper respiratory infections, 
weight loss, tachycardia when standing up, coughing up sputum, wheezing, increased 
breathlessness, skin problems (panniculitis), short-term memory problems, chronic pain, 
and sleep disturbances (Alpha-1 Awareness, 2017).  Current medical treatment protocols 
involve the use of inhalers, nebulizers, corticosteroids, oxygen therapy, Lasix, CPAP 
machine, short-term pulmonary rehabilitation, and lung transplants for the most severe 
cases (Anariba, 2017).  There are a variety of gene combinations that physicians use to 
determine the severity of the symptoms which are discussed in Chapter 2. 
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Early onset panacinar emphysema is an indication that an individual may have 
AAT-D and should be tested (Anariba, 2017).  However, in the early stages of being 
symptomatic, it takes an average of seven to eight years to be properly diagnosed 
(Campos, Wanner, Zhang,& Sandhaus, 2005).   The physical demands that are placed on 
AAT-D patients, as well as the severity of the symptoms and the uncertainty of AAT-D, 
have an impact on the psychological state of AAT-D patients.    
High levels of depression and anxiety are common among AAT-D patients as 
they cope with challenges of AAT-D (Barnett, 2004; de Voogd et al., 2011; Figueirdo et 
al., 2014; Hoth et al., 2015).  However, family caregivers are also affected by the disease, 
according to researchers.  The disruptions of family life, the tasks and activities 
associated with providing care, the length of time caregiving for the patient, as well as the 
physical condition of the patient, may heighten the degree of stress for the family 
caregiver (Lee et al., 2010).  Caregivers for COPD patients may observe their family 
member with COPD experience progressive dyspnea, physical disabilities, altered 
cognition, memory disturbances, and behavioral changes that will further strain the 
family caregiver’s overall life (Lee et al., 2010). How AAT-D patients and their family 
caregivers experience and cope with the complexities and challenges of AAT-D is further 
discussed in Chapter 2.  
Problem Statement 
AAT-D is a disease characterized by the development of lung disease and/or liver 
damage in adults between 20-50 years old (Alpha-1 Association, 2015). Individuals will 
not know that they have the disorder unless their doctor views the specific signs and 
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symptoms and asks for the designed blood examination which directly tests for alpha -1 
deficiency (Alpha-1 Association, 2015).  Some of the most common symptoms of this 
disease are wheezing, weight loss, reoccurring respiratory infections, insomnia, short 
term memory loss, shortness of breath, and tachycardia upon standing (Alpha-1 
Association, 2015). There is no cure for the disease, only management, which involves 
the use of bronchodilators; corticosteroids; augmentation infusions once a week as a goal 
to replace the missing enzyme that is needed to help preserve the liver and lungs; and, in 
the most severe cases, lung transplants (Alpha-1 Foundation, 2017).  Hence, the treatment 
measures are determined by the combination of inherited genes.  For instance, one copy 
of each gene is inherited from each parent to create two copies of the alpha-1 antitrypsin 
(AAT) gene which may come in three forms: M, S, and Z (Suri, 2015).  However, the 
amount of AAT that is produced and the severity of the disorder are determined by the 
combination of the genes that were developed (Suri, 2015).  
Since 1963, researchers have striven to unveil the complexity of AAT-D and how 
to better detect and manage the disease. However, it has been a slow process, and it was 
not until 1989 that augmentation therapy was first administered within the United States 
and 2007 that the first genetic counseling was offered (Alpha-1 Awareness, 2017).  
Although researchers continue to discover the underlining issues with alpha-1 deficiency, 
the challenge remains in early and proper diagnoses.  For example, AAT is often 
undetected or misdiagnosed with only 5% of cases being diagnosed in the estimated 
100,000 affected individuals in the United States, especially in its early stages, the 
disease also takes an average of seven to eight years after symptoms develop to be 
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properly diagnosed (Campos et al., 2005). COPD is an umbrella term used to describe 
various respiratory disorders, such as bronchectasis, chronic bronchitis, asthma, 
emphysema, and Alpha-1 deficiency. In particular, Alpha-1 deficiency is a genetic 
subtype of COPD (Hoth et al., 2015). 
Previous researchers have examined the interactions between family caregivers 
and their patients.  For example, researchers have focused on coping strategies, such as 
problem-solving strategies, emotional-cognitive strategies, and stress management 
strategies, among COPD patients and family caregivers (Barnett, 2004; de Voogd et al., 
2011; Figueirdo et al., 2014; Hoth et al., 2015); COPD patients’ experiences (Barnett, 
2004; de Voogd et al., 2011; Figueirdo et al., 2014; Hoth et al., 2015 ;), how dyspnea in 
COPD patients may increase anxiety level, (Barnett, 2004; de Voogd et al., 2011; 
Figueirdo et al., 2014; Hoth et al., 2015  ),  how the severity of the symptoms may impact 
alpha-1 patients’ quality of life, (Barnett, 2004; de Voogd et al., 2011; Figueirdo et al., 
2014; Hoth et al., 2015   ), and how illness uncertainty may increase anxiety levels 
(Barnett, 2004; de Voogd et al., 2011; Figueirdo et al., 2014; Hoth et al., 2015).  In 
addition, a study was conducted to examine and compare family caregivers of people 
with early stages of COPD to those family caregivers of people with advanced COPD, 
using a cross-sectional design with a convenience sample (Figuerido, Gabriel, Jacomes, 
Cruz, & Marques, 2014).  The author, Figuerido et al., discovered that family caregivers 
of people with early COPD used fewer coping strategies compared to those family 
caregivers of advanced COPD individuals (Figuerido et al., 2014).  However, the 
problem-focused coping strategy proved to be the most helpful between the two groups 
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(Figuerido et al., 2014).  In another study, an analysis was performed to examine from a 
phenomenological approach the experiences of individuals living with COPD (Barnett, 
2004).  The author, Barnett found that the breathlessness described by the COPD patients 
was considered the most difficult symptom which to lead to anxiety and the feeling of a 
lost role within the patient’s family (Barnett, 2004). 
Dyspnea has been associated with general anxiety, and it appears that it may 
influence activities of daily living (DeVoogd et al., 2011).  Hoth et al. (2015) examined 
illness uncertainty, such as ambiguity and complexity, among alpha-1 deficient-
associated COPD patients was examined.  The authors suggested that uncertainty about 
physical symptoms (ambiguity) induced depression, anxiety, and breathlessness while 
decreasing alpha-1 deficient patients’ quality of life (Hoth et al., 2015).  In contrast, 
uncertainty about treatment and the health care system (complexity) did not have an 
independent effect on any of the outcomes (Hoth et al., 2015).  Although these findings 
suggest an association between increased dyspnea with anxiety and the types of coping 
strategies used among those with COPD, the studies have limitations.  For instance, 
Figuerido et al. (2014) used quantitative measures and elicited limited perspectives from 
family caregivers on coping strategies.  The authors of the second and third studies, 
Barnett (2004) and de Voogd et al. (2011), recruited either participants they knew or 
recruited individuals from a pulmonary rehab program, suggesting that the results may 
not represent all COPD patients and leading to a selection bias.  Finally, the authors of 
the fourth study, Hoth et al., had a reduced sample.  For example, the study initially had 
1,727 alpha-1 subtype COPD participants, but only 407 completed the study (Hoth et al., 
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2015).  Hence, the study may not properly represent entire alpha-1 associated COPD 
population.   
Further qualitative research appears to be needed to better understand the 
complexity of alpha-1 deficiency and how psychological distress and disease specific 
anxieties are placed on both the alpha-1 deficient patients and their family caregiver.  
Moreover, an analysis of the specific coping strategies used by both alpha-1 deficient 
patients and their family caregivers should be further investigated in order to gain a 
deeper insight into the alpha-1 deficient patient and their family caregiver’s personal 
experiences living and managing the illness.  Many Alphas appear to require caregivers 
to help assist with their treatments, activities with daily living, and finances.  Hence, in 
this qualitative study, I assessed common themes and coping strategies used across the 
alpha-1 community and how the family unit is impacted daily.  For instance, I probed 
how family caregivers manage their finances while taking care of an alpha-1 deficient 
family member.  In addition, I evaluated both the Alpha-1 deficient individual’s and the 
family caregiver’s emotional responses to the complexity of the illness and the added 
demands of financial circumstances. 
Purpose of the Study 
The purpose of this qualitative study was to examine the experiences of being an 
Alpha-1 patient and a family caregiver for someone living with Alpha-1 deficiency.  In 
addition, I sought to examine coping strategies among alpha-1 deficient patients and their 
family caregivers. 
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Research Questions 
I sought to answer four research questions (RQ): 
RQ1. How do AAT-D patients describe living with their illness? 
RQ2. How do the family caregivers who live with AAT-D patients describe their 
experiences? 
RQ3. What are the common coping strategies among AAT-D patients? 
RQ4. What are the common coping strategies among the family caregivers? 
Theoretical Foundation 
The current study involved in-depth interviews given to Alpha-1 patients and their 
family caregivers based upon the biopsychosocial model, Bowen’s family systems 
theory, and the family systems model of illness.  The biopsychosocial model offers a 
broad view of disease and attributes disease outcomes to the intricate variable interaction 
of biological factors, such as genetics; psychosocial factors, such as mood and behavior;  
and social factors involved with family (Lakhan, 2006). The model also allows for 
understanding of the factors’ complex interactions in health, illness, and health care 
delivery (Lakhan, 2006).   
Bowen’s (1974) family systems theory relies on the patterns that develop in 
families in order to defuse anxiety and bridges the patient’s disease state with psychology 
in order to treat the whole patient.  Moreover, it stresses the concept of wellness where 
the state of being in good health is accompanied by good quality of life and strong 
relationships as cited in (Lakhan, 2006).   
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The family systems model of illness uses the family as the interactive focal point 
and pivots on the concept of a systemic interaction between an illness and family that 
evolves over time (Rolland, Emmanuel, & Torke, 2017).  The model distinguishes three 
dimensions.  First, it incorporates psychosocial types of health conditions, based on the 
pattern of onset, course, outcome, disability, and level of uncertainty (Rolland et al., 
2017).  Second, the major developmental phases throughout the disease process are 
observed (Rolland et al., 2017).  Third, key family system variables, such as organization, 
communication, family life course development, belief systems, and outlook, are also 
analyzed (Rolland et al., 2017).  I further discuss the study’s theoretical foundations in 
Chapter 2.  
Nature of the Study 
For this study I used the qualitative method and a phenomenological design based 
on individual interviews. Latham (2017) suggests that a minimum of 12 homogenous 
participants is needed to ensure saturation.  Although, additional participants will not 
provide any added insight, 15 participants are suggested by Latham as a minimum for 
most qualitative interview studies with homogenous groups (Latham, 2017).  For this 
reason, I recruited a total of 16 participants, eight of whom had been diagnosed with 
alpha-1 deficiency and eight of whom were caregivers for alpha-1 deficient individuals 
(siblings, parents, or spouses). I recruited participants by advertising on alpha-1’s social 
media support page and sending out e-mails to the alpha-1 community with the help from 
the director of the national organization of alphas.  In-depth interviews were incorporated 
to gain a deeper understanding of the complexity of the illness and how coping strategies 
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may differ across Alpha-1 patients and their family caregivers.  In addition to 
highlighting the common coping strategies used by Alpha-1 deficient patients and their 
family caregivers, study findings provide insight into the complexity of the illness from a 
psychological perspective. 
Definitions 
Alpha-1 antitrypsin deficiency: An inherited disease which is passed from parents 
to their children through their genes.  It may result in serious lung disease in adults and/or 
liver disease at any age (Alpha-1 Foundation, 2017). 
Burden of care: Disruptions of family life, the tasks and activities associated with 
providing care, the length of time caring for the patients, as well as the physical condition 
of the patients which may heighten the stress of the caregivers (Lee et al., 2010). 
Caregiving burden: The distress that caregivers feel as the result of providing 
care.  It is specific to the complexity and the degree of the disease care and varies from 
anxiety and depression to other emotional and more general responses which may 
heighten sleep disturbances, fatigue, and pain of the caregivers (Rha, Park, Sang, Lee, & 
Lee, 2015). 
Chronic obstructive pulmonary disease: An inflammatory condition of the lungs 
that causes the airflow of the lungs to become blocked (Mayo Clinic, 2017). 
Dyspnea: A term used to describe individuals who experience difficulty breathing 
(Alpha-1 Foundation, 2017). 
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Assumptions 
I had several assumptions when conducting the study. For instance, during the 
interview process, I assumed that the participants would be truthful in their responses and 
would appropriately represent the alpha-1 community. 
Scope and Delimitations 
 In this qualitative study, I recruited participants who had been diagnosed with 
AAT-D, who currently did not smoke, and who lived in Florida.  Choosing these criteria 
helped keep the sample as homogeneous as possible and prevented external variables, 
such as other COPD issues, smoking, or various weather conditions from potential 
altering the results.  In addition, I only evaluated family caregivers who lived with their 
AAT-D relative order to establish a homogenous sample and limit external factors from 
influencing the data.  
The population of interest was AAT-D individuals and their family caregivers 
who live in Florida.  I recruited the sample through the Alpha-1 Association’s Facebook 
page and e-mail system.  Therefore, the sample consisted of participants who had access 
to a computer, used Facebook, and were members of the Alpha-1 Association’s Facebook 
group. I met participants in a public location (such as a library) close to where I live if 
there were participants who were too ill or who did not live near me, I administered 
phone interviews.  The AAT-D participants had separate interviews from their caregivers 
to ensure that their caregivers would not be able to influence their answers, and vice 
versa. 
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Limitations 
I interviewed 16 participants who lived in the southern part of the United States 
who had access to a computer and were a part of the National Foundation for Alphas 
Facebook group.  Eight participantshad been diagnosed with AAT-D and did not 
currently smoke; the other eight participants were the primary family caregiver for their 
AAT-D family member. Because participant recruitment was limited to only those 
participants who have access to a computer, a Facebook account, and membership in the 
National Foundation for Alphas Facebook group, findings may not be generalized  toto 
the broader proportion.  In addition, the specificity of recruiting participants from the 
southern portion of the United States may have resulted in participants being different 
from other demographics.  Results also may not be generalizable across the alpha 
community due to the small sample size and because people who chose to volunteer for 
the study may have had a different perspective than those who chose not to volunteer.  
Moreover, the use of a phenomenological approach and interpretive data limits 
generalizability compared to a quantitative study which provides data that can be 
measured, expressed and clearly defined (Sven, A., 2014).   
Significance 
The present study filled the gap in understanding by focusing on the coping 
mechanisms both Alpha-1 patients and their caregivers use daily. In turn, the study 
provided a deeper insight into the complexity of alpha-1 deficiency, coping strategies, 
and family unit in which possible additive care could be a part of the standard medical 
protocols. For example, a monthly visit with a specialized therapist could consult both the 
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patient individually as well as the family as a whole. Additionally, behavioral tools could 
be designed to fit the needs of each patient in order to help his or her severity of the 
illness. Moreover, this research exhibited a critical analysis to serve a better role in 
defining how to bring forth increased awareness and detection of the illness through 
gathering the personal experiences on how each of the patients was diagnosed and how 
long it took to appropriately be diagnosed and placed on a treatment plan. Hence, 
discovering the common denominator from the alpha-1 patients’ medical history helped 
develop a plan of action needed to improve the attention Alpha-1 deficiency. 
Summary 
AAT-D is characterized by the development of COPD and/or liver damage in 
adults between the ages of 20-50 years old or liver disease in children.  Thus, no one will 
ever know they have it unless doctors can recognize the specific signs and symptoms and 
ask for the designed blood examination which directly tests for AAT-D (Alpha-1, 
Foundation, 2017).  Previous research has shown that there is a high rate of undetected or 
misdiagnoses of AAT-D (Campos et al., 2005).  Moreover, the uncertainty and 
complexity of COPD has been exhibited to be stressful for both AAT-D patients and their 
family caregiver, as well as the degree of importance the interaction between the COPD 
patient and their family caregiver has on how they cope with the disease’s demands 
placed on the family unit (Barnett, 2004; deVoogd et al., 2011; Figuerido et al., 2014; 
Hoth et al., 2015; Stenzel et al., 2015).  However, additional research needs to discover 
the complexity of AAT-D associated COPD and the disease’s specific anxieties that are 
placed on both the AAT-D patient and their primary family caregiver.  The proposed 
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qualitative study searched to understand both the AAT-D patient and their family 
caregiver’s experiences, as well as uncovered the most common coping strategies used by 
the AAT-D patient and their family caregiver daily.  This chapter will be followed by a 
review of the pertinent literature in Chapter 2.  Chapter 3 will follow with a description of 
the study design, participants, procedures, assessments used and how any information 
gathered will be assessed.  
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Chapter 2: Literature Review 
Introduction 
(COPD) is an umbrella term used to describe progressive lung disease including 
emphysema, chronic bronchitis, asthma, and some forms of bronchiectasis (COPD 
Foundation, 2017).  (AAT-D) is a relatively common genetic disorder that is often 
undiagnosed.  AAT-D is a disorder that is related to COPD which is caused by a 
deficiency of the alpha-1 protein in the bloodstream; people with AAT-D are predisposed 
to COPD and liver disease (Anariba, 2017).  Without this protein, white blood cells begin 
to harm the lungs, and lung deterioration occurs (Anariba, 2017).  AAT-D is a deficiency 
that is characterized by the development (COPD)and/or liver damage in adults between 
the ages of 20 and 50 years old or liver disease in children (Alpha-1 Awareness, 2015).  
Individuals will not know they have the disease unless their doctor recognizes the 
specific signs and symptoms and asks for the designed blood examination which directly 
tests for alpha-1 deficiency (Alpha-1 Awareness, 2015).  Although there is no cure for the 
disease, management of the illness entails the use of bronchodilators, corticosteroids, and 
augmentation infusions once a week as a goal to replace the missing enzyme that is 
needed to help protect the liver and lungs from hazards (Alpha-1 Foundation, 2017).  
Since 1963, researchers have striven to unveil the complexity of the disease and how to 
better detect and manage the disease.  However, it has been a slow process, and it was not 
until 1989 that augmentation therapy was first administered within the United States and 
2007 when the first genetic counseling was offered (Alpha-1 Awareness, 2017).  
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Caregiving refers to the experience and tasks involved in providing assistance to a 
family member who is no longer independent (Lee et al., 2010). In providing care, 
caregivers experience a high level of burden, according to researchers. Hence, burden of 
care is considered the extent to which caregivers perceive their emotional and/or physical 
health, social life, and financial status to suffer as the result for caring for their relative 
(Lee et al., 2010).  Moreover, the disruptions of family life, the tasks and activities 
associated with providing care, the length of time caregiving for the patient, as well as the 
physical condition, of the patient may heighten the degree of stress for the family 
caregiver (Lee et al., 2010).  Caregivers for COPD patients may observe their family 
member with COPD experience progressive dyspnea, physical disabilities, altered 
cognition, memory disturbances, and behavioral changes that will further strain the 
family caregiver’s overall life (Lee et al., 2010).  
Despite researchers’ continued efforts to discover the underlying issues with 
alpha-1 deficiency, the challenge still appears to remain in how to better detect, manage, 
and treat the patient’s individual mental and physical needs, as well as their patient’s 
family as a whole unit.  Moreover, the common coping strategies that help alpha-1 
patients and their caregivers live a better quality of life, as well as prevail over the 
challenges from the disease each day, still appear to further need researched.  Previous 
researchers appeared to have focused on how illness uncertainty, depression, and anxiety 
play a role in both COPD patients and their caregivers’ quality of life. In addition, past 
literature has suggested that specific psychosocial resources, coping styles, and CBT have 
an impact on the way COPD patients manage their illness.  However, few researchers 
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have specifically examined how alpha-1 deficient-associated COPD patients’ commonly 
use coping strategies that help them live a better quality of life, according to my review 
of the literature.  Furthermore, there has been little focus on how alpha-1 patients’ family 
caregivers (spouses and/or children) cope with their personal challenges daily.  In the 
current study I examined both alpha-1 patients and their caregivers’ coping strategies and 
evaluated factors that helped them manage the illness better than others. In this chapter, I 
will describe my literature search strategy and provide an overview of my theoretical 
foundation before revising relevant literature. I used literature mostly from COPD studies 
because there appears to have been fewer studies that have focused on AAT-D-related 
COPD.  
Literature Search Strategy 
I used several resources to conduct the literature review.  I searched the PsychInfo 
database, nursing journals and the national library of medicine using the general search 
terms COPD and Alpha-1 antitrypsin deficiency as the root of all inquiries.  With these 
terms, other search words such as anxiety, depression, coping strategies, alpha-1 
deficient patients, and family caregivers were used to narrow the search.  The articles that 
were found from these search strategies helped to produce additional resources and 
authors the general search did not discover.  The online Walden University Library 
provided many of the needed articles for this review.  Additionally, Alpha-1 Awareness 
and Alpha-1 Foundation provided additional resources that helped describe the 
complexity of the disease, its treatments, and overall prognosis.  
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Theoretical Foundation 
The current study involved in-depth interviews given to Alpha-1 patients and their 
family caregivers based upon both the biopsychosocial model (Engel, 1977) and Bowen’s 
(1974) family systems theory.  The biopsychosocial model focuses on disease outcomes 
to the intricate variable interaction of biological factors, such as genetics; psychosocial 
factors, such as mood and behavior; and social factors involved with family (Lakhan, 
2006).  Clinicians use Bowen’s family systems theory (Bowen, 1974) to analyze the 
patterns that develop in families in order to defuse anxiety and bridge the patient’s 
disease state with psychology in order to treat the whole patient.  Moreover, Bowen’s 
thery stresses the concept of wellness where the state of being in good health is 
accompanied by good quality of life and strong relationships (Lakhan, 2006).  
Over the years, medical providers have mainly utilized the biomedical model, 
which focuses on the physical causes of disease (Lakhan, 2006).  However, in the 1970s 
an American psychiatrist George Engel was one of the first practitioners to focus on 
implementing patient-centered practices to address the psychological and social 
dimensions of patients’ health concerns within the health care system (The 
“Biopsychosocial Approach,” 2006).  Engel developed the biopsychosocial model which 
considers biological, psychological, and social factors and their complex interactions in 
understanding health, illness, and health care delivery (“The Biopsychosocial Approach,” 
2006).   While the biomedical approach takes a reductionist view, the biopsychosocial 
approach recognizes that different clinical scenarios may be best understood scientifically 
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at several levels of the natural systems continuum (“The Biopsychosocial Approach,” 
2006).   
For instance, Block and Dorstyn (20105) used the biopsychosocial model was to 
evaluate the resilient levels of individuals who have been diagnosed with Multiple 
Sclerosis.  The researchers used the biopsychosocial model to examine the interplay 
between the individuals’ coping skills, behaviors, and thoughts, as well as social and 
environmental resources (Block & Dorstyn, 2015).  As a result, the study helped bring 
forth some insight into how these individuals can achieve optimal functioning.  For 
example, psychological variables, like self-efficacy, directly and significantly contributed 
to resilient levels in the sample (Block & Dorstyn, 2015). Additionally, disability-specific 
variables, such as fatigue and physical independence in conjunction with social support, 
exhibited influential resilience indirectly (Block & Dorstyn, 2015).   
Studies have also shown that illness-related variables, such as time of diagnosis 
and severity, play an influential role in the individual’s coping mechanisms.  For 
example, (COPD) patients have exhibited an association between passive coping and 
poorer physical health (Manne, 2002).  I used the biopsychosocial modelin the current 
study to evaluate coping strategies from the perspectives of alpha-1 patients and their 
family caregivers, as well as provide a deeper insight into the complexity of the 
interaction between family caregivers, patients’ illness, the behavior, environment, and 
social experiences. 
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Bowen Family Systems Theory 
The Bowen family systems theory of human behavior views the family as a 
synergistic emotional support unit which uses system thinking to describe the complex 
interaction within the family.  Hence, families affect their members’ thoughts, feelings, 
and actions. It is the connectedness and reactivity which makes the functioning of the 
family members interdependent (The Bowen Center, 2017).  Bowen recognized this 
theory and its eight interlocking concepts, such as triangles (involves a three person 
relationship which may cause tension that shifts around the three relationships), 
differentiations of self, nuclear family emotional process, family projection process, 
multigenerational transmission process, emotional cutoff, sibling position, and societal 
emotional process (The Bowen Center, 2017).  
Studies have examined how coping strategies and quality of life among the 
chronically ill and their caregivers may be synergistic with each other.  For instance, in 
one study that used Bowen’s Family System Theory to focus on patients and caregivers 
for those individuals with a complex neurological and palliative diagnosis found that 
family was an important emotional unit, suggesting that the stronger underlying 
attachment bonds between family members the more resilient they were under emotional 
pressure (Draper et al., 2013).  Furthermore, other studies in which evaluated patients and 
their caregivers’ relationship was a study that examined how lung transplant patients and 
their caregivers perceived their quality of life.  Results proposed that while patient and 
caregiver quality of life (QOL) were related to each other, individual coping was 
exhibited (Myaskovsky, Dew, Switzer, McNulty, DiMartini, & McCurry, 2004).  More 
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specifically, in families living with chronic illness, strong reciprocal effects existed 
between patient’s and caregiver’s QOL; however, the caregivers’ coping strategies 
differed from the patients’ well-being (Myaskovsky et al., 2004).  In turn, incorporating 
the biopsychosocial model and Bowen’s Family System Theory helped evaluate both the 
Alpha-1 patients’ and their family caregivers lived experiences, as well as their coping 
strategies used, which connected the disease state from the patients with their 
perspectives involved within their family dynamics.  
Family Systems Model of Illness 
 When patients are faced with the challenges of a debilitating disease, family 
caregivers must take the lead in both making medical decisions and advocating for the 
patients.  The family systems approach to clinical practice has become essential to the 
understanding and treatment of individual and relational disorders (Rolland et al., 2017).  
Research evidence supports involving families in assessment and treatment and for the 
mutual influence of family functioning, health, and physical illness, as well as the 
usefulness of family centered interventions with chronic conditions.  The FSI model 
provides a useful framework in clinical practice and research with families dealing with 
chronic and life threatening diseases (Rolland et al., 2017).  Thus, taking the family as the 
focal point, this model can base the concept of a systematic interaction between an illness 
and family that evolves over time.  Moreover, the FSI model can be used to analyze the 
association between the psychosocial demands of the disorder over time and the family 
style of how they function, cope, and adapt to the progressive changes of the chronic 
disorder (Rolland et al., 2017).  
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For example, a qualitative research study was conducted using the Family 
Systems Illness Model in order to better understand the experiences of families dealing 
with COPD, predominantly in the chronic phase of the illness.  The findings showed that 
restraints in the family social life represented a significant lifestyle change for both 
patients and their family caregivers, secondary to the symptomatic challenges of COPD 
(Gabriel et al., 2014).  The results exhibited that patients felt deprived from family and 
social activities as a consequence of the progressive COPD related fatigue, sleep 
disturbances, breathlessness, and difficulty in mobility. Hence, leaving them to feel sad, 
lonely, or abandoned (Gabriel et al., 2014).  There was also data that exhibited how the 
COPD patient’s extended family members and/or caregiver felt isolated from society.  
Momentary breathlessness, long-term oxygen therapy and treatment regimen 
adherence place high demands on family caregivers which limited the caregivers own 
social activities and relationships (Gabriel et al., 2014).  Gabriel et al. (2014) suggested 
that the family caregivers tend to define themselves based solely upon their family 
member’s illness and personal experiences.  Thus, as recommended by the FSI model, 
interventions should be implemented to help family members cope with the demands of 
the disease, as well as raise community awareness, enhance social networks and support 
while enabling self-care (Gabriel et al., 2014).  
 COPD patients often have other diseases and are at an increased risk for 
contracting infections, having anxiety, and/or depression, and are frequently hospitalized.  
The primary goal for most health care policies is to reduce the number of hospital stays 
and limit long term care services which places an increased demand on family members 
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to care for the COPD patients at home (Gautum, Werner, Lucas, 2012).  According to 
previous studies from Norway and other Western countries, the main caregivers to the 
chronically ill are spouses and children (Gautum et al., 2012).  The next section explored 
the previous research that has been examined for mostly COPD patients and their 
caregivers, as well as AAT-D patients and their caregivers which created the foundational 
literature necessary to help the current study focus on the coping strategies from both 
AAT-D patients and their caregivers’ perspectives used daily. 
Literature Related to Key Concepts and/or Variables 
 Like many chronic diseases, Alpha-1 antitrypsin deficiency not only places stress 
on the patient’s physical and psychological quality of life but also impacts their 
caretakers.  The following literature review provided an insight into the complexity of 
alpha-1 antitrypsin deficiency and the coping strategies used among alpha-1 deficient 
patients and their caretakers.   
Alpha-1 Antitrypsin Deficiency 
Alpha-1 antitrypsin (AAT) is a protein that is normally found in the lungs and 
bloodstream and helps protect the lungs from diseases, such as emphysema and chronic 
obstructive pulmonary disease (COPD).  This disease is related to a high risk for 
development of jaundice in infants, liver disease in children and up to 50% of adults with 
AAT are affected by liver disease (de Serres, Bianco, & Fernandez, 2003).  AAT-D is 
one of the three most common lethal genetic diseases among adult white persons, 
affecting one per 3,000 to 5,000 individuals. Severe AAT-D affects an estimated 70,000 
to 100,000 individuals with approximately 25 million people who carry at least one 
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deficient gene (Anariba, 2017).  World- wide, white persons constitute approximately 
117 million carriers and 3.4 million are affected. Although, AAT-D is most commonly 
found in individuals of Northern European and Iberian descent, it has been identified in 
all populations (Anariba, 2017). 
 Some people either do not make enough of the AAT or create abnormal types of 
it, which may cause AAT deficiency (Thompson & Yoneda, 2017).  Specifically, AAT 
deficiency is a heritable, autosomal recessive metabolic disease that results in the 
synthesis and secretion of defective AAT.  Some of the abnormal AAT is retained as 
pathological polymers within the endoplasmic reticulum of the hepatocytes, resulting in a 
low plasma concentration.  In turn, this deficit usually is insufficient to ensure a lifetime 
protection of the lungs from the proteolytic damage of neutraphil elastase, causing early 
onset of panlobular pulmonary emphysema (de Serres et al., 2003).  AAT deficiency is 
suspected to promote asthma, bronchiectasis, systemic vasculitis, relapse panniculitis, 
rheumatoid arthritis, intracranial arterial dissection, and multiple sclerosis (de Serres et 
al., 2003).  
On the other hand, if one were to receive only one changed gene then they will 
not have the disease but be a carrier.  However, some people who are carriers may still 
experience mild symptoms of alpha-1 antitrypsin deficiency (Thompson & Yoneda, 
2017).  Studies suggest that AAT-deficiency carrier phenotypes (PiMS and PiMZ) and 
deficiency allele phenotypes (PiSS, PiSZ, and PiZZ) are suspected to make subjects 
susceptible to a variety of other adverse health related effects (de Serres et al., 2003).  
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There is a variety of gene combinations in which determines the severity of the 
symptoms.  For instance, the most common allele is called M, producing normal levels of 
AAT. Most people in the general population have two copies of the M allele (MM) in 
each cell (de Serres et al., 2003).  Other versions of the gene lead to reduced levels of 
AAT, such as S allele in which produces moderately low levels of the AAT protein and 
the Z allele that produces little to no AAT.  Thus, individuals with two copies of the Z 
allele (ZZ) in each cell are likely to have AAT-deficiency and those with the SZ 
combination have an increased chance for developing lung disease (de Serres et al., 
2003).  It is estimated worldwide that 161 million people have one copy of the S or Z 
allele and one copy of the M allele in each cell (MS or MZ).  Individuals with an MS or 
SS combination usually produce enough AAT to protect the lungs.  However, people 
with MZ alleles have a slight increased risk of impaired lung or liver function (de Serres 
et al., 2003).  
Alpha-1 antitrypsin deficiency was discovered in 1963 by Laurell and Erisksson 
(Anariba, 2017).  Laurell and Eriksson found that in five of the 1500 serum protein 
electrophoreses (SPEP) submitted to his laboratory in Sweden had the absence of the 
band of alpha-1 protein.  Moreover, Laurell and Eriksson discovered that three of the five 
patients were diagnosed with emphysema at a young age, leading them to develop the 
cardinal clinical features of AAT-deficiency with absence of the AAT and early onset 
emphysema (Anariba, 2017).  For example, people whose bodies do not produce enough 
of the protein AAT are more likely to develop emphysema typically between the ages 30-
40 years old.  Physicians should suspect AAT-deficiency if the patient develops 
26 
 
emphysema at 45 years of age or younger, develops emphysema without having any 
recognized risk factors, such as smoking, chemical fumes, or pollutants over a long 
period of time, x-rays show less density in the lungs than normal, have unexplained liver 
disease, necrotizing panniculitis, bronchectasis without any cause, or asthma that does not 
completely resolve after the use from regular breathing treatments (Fahy, Laureaus, & 
Week, 2014).  Although AAT is a common genetic condition, less than 10% of severely 
deficient individuals are currently identified (Anariba, 2017).  People with AAT-
deficiency are predisposed to COPD and liver disease, such as cirrhosis and 
hepatocellular carcinoma in children and adults. 
Alpha-1 antitrypsin deficiency can occur in all ethnicities, but it is most 
commonly seen in white or European descent individuals.  Early onset panacinar 
emphysema is an indication that an individual may have Alpha-1 antitrypsin deficiency 
and should be tested (Anariba, 2017). Alpha-1 antitrypsin deficiency (AATD) is 
considered one of the three most lethal genetic diseases among white adults, affecting one 
per 3000 – 5000 individuals and about one to five percent of those patients diagnosed 
with chronic obstructive pulmonary disease are estimated to have alpha-1 antitrypsin 
deficiency (Anariba, 2017).  Severe AATD affects an estimated 70,000 -100,000 
individuals and approximately 25 million people carry at least one deficient gene. 
However, less than 10% of severely deficient individuals have been properly identified 
(Anariba, 2017).  
There is no cure for the disease, only management, which involves treatment 
measures from the use of bronchodilators, corticosteroids, augmentation infusions to lung 
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transplants in the most severe cases (Alpha-1 Foundation, 2017).  Moreover, pulmonary 
rehabilitation that includes exercise training, nutritional counseling, education, energy 
conserving techniques, breathing strategies, and psychological counseling along with the 
standard medical treatment is advisable (National Heart, Lung, & Blood Institute, 2017).  
Furthermore, patients should be directed to avoid lung irritants, such as pollen, ash, air 
pollution, wood burning stoves, paint and cleaning fumes, as well as to maintain a 
healthy nutritional plan involved in smaller meal portions, vegetables, fruits, whole 
grains, lean protein, and fat free or low-fat dairy products (National, Heart, Lung, & 
Blood Institute, 2017).   In addition, patients would be recommended to learn how to 
reduce stress through meditation, yoga, and breathing exercises as a goal to positively 
cope with the disease.   
Since 1963, researchers have strived to understand the complexity of the disease 
and how to better detect and manage the disease.  However, it has been a slow process 
and it was not until 1989 that augmentation therapy was first administered within the 
United States and in 2007 the first genetic counseling became offered (Alpha-1 
Awareness, 2012).  Although researchers continue to discover the underlining issues with 
alpha-1 deficiency, the challenge still remains in early and proper diagnoses.  For 
example, AAT is often undetected or misdiagnosed with only 5% of cases being 
diagnosed in the estimated 100,000 affected individuals in the United States, especially in 
its early stages and takes an average of seven to eight years after symptoms develop to be 
properly diagnosed (Campos et al., 2005).  
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Chronic Obstructive Pulmonary Disease (COPD) is an umbrella term used to 
describe various respiratory disorders, such as bronchectasis, chronic bronchitis, asthma, 
emphysema, and Alpha-1 deficiency. In particular, Alpha-1 deficiency is a genetic 
subtype of COPD (Hoth et al., 2015).  
Previous related research has examined the interactions between family caregivers 
and their patients, for example, research has focused on the coping strategies, such as 
problem-solving strategies, emotional-cognitive strategies, and dealing with the stress 
consequences strategies between COPD patients and family caregivers, COPD patients’ 
experiences, how dyspnea in COPD patients may increase anxiety levels, how the 
severity of the symptoms may impact alpha-1 patients’ quality of life, and how illness 
uncertainty may increase anxiety levels (Barnett, 2004; de Voogd et al., 2011; Figueirdo 
et al., 2014; Hoth et al., 2015).  
Further qualitative research is needed to better understand the complexity of 
alpha-1 deficiency and how psychological distress and disease specific anxieties are 
placed on both the alpha-1 deficient patients and their family caregiver.  Moreover, an 
analysis of the specific coping strategies used from both alpha-1 deficient patients and 
their family caregivers should be further investigated in order to gain a deeper insight into 
the alpha-1 deficient patient and their family caregiver’s personal experiences living and 
managing the illness.  Many Alphas require caregivers to help assist with their 
treatments, activities with daily living, and finances. Hence, in the proposed qualitative 
study I will examine common themes and coping strategies used across the alpha-1 
community and how the family unit is impacted on a daily basis.  For instance, I will look 
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deeply into how the family caregiver manages their finances while taking care of an 
alpha-1 deficient family member.  In addition, I will evaluate both the Alpha-1 deficient 
individual and their family caregiver’s emotional responses to the inter-relation of the 
complexity of the illness and the added demands of financial circumstances. 
Impact of Illness Uncertainty on COPD Patients 
The perceived uncertainty about the current symptoms and future prognosis is the 
challenging part of living with a chronic illness.  The uncertainty illness theory states that 
uncertainty occurs when a person is unable to understand the meaning of the illness and 
predict the likelihood of the treatment, as well as the prognosis (Hoth et al., 2015). Hoth 
et al. (2015) analyzed illness uncertainty, such as ambiguity (physical symptoms) and 
complexity (treatment and healthcare system) among alpha-1 deficient associated COPD 
patients and found that uncertainty about physical symptoms (ambiguity) induced 
depression, anxiety, breathlessness while decreasing alpha-1 deficient patients’ quality of 
life.  In contrast, uncertainty about treatment and the healthcare system (complexity) did 
not have an independent effect on any of the outcomes stress.  As alpha 1-deficiency is 
closely related to COPD, and little research has specifically examined alpha 1, the 
literature related to COPD will also be examined. 
The trajectory of COPD is unpredictable and shows a slow decline interspersed 
with acute exacerbations of the physical symptoms, such as re-current respiratory 
infections and severe dyspnea.  Moreover, the combination of the uncertainty of the 
exacerbations and the increased fear of death becomes apparent.  Recent studies show 
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that the diagnosis of a life-threatening illness, such as COPD can trigger end-of-life fears 
through the awareness of death salience (Stenzel et al., 2015).  
In a study conducted by Stenzel, Vaske, Kuhl, Kenn, and Rief, (2015) the 
researchers documented that the diagnosis of a life threatening illness, like chronic 
obstructive pulmonary disease (COPD) can trigger end-of-life fears.  Early studies have 
shown that these fears can play critical roles in a COPD patient’s life.  In particular, the 
authors investigated the relevance of socio-demographic variables, illness severity, 
psychological distress, and disease specific anxiety as predictors of end-of-life fears in 
COPD (Stenzel et al., 2015).  They found that illness severity was not a predictor of end-
of-life fears but gender and psychological distress explained augmented differences.  
When disease specific anxieties were included as additional predictors, psychological 
distress was no longer significant.  On the other hand, disease specific anxieties mediated 
the association between psychological distress and end-of-life fears (Stenzel et al., 2015).  
In the next section, studies will be highlighted to provide additional information on how 
the challenges of alpha-1 deficiency play a role in alpha-1 deficient individual’s coping 
mechanisms.  Understanding the importance of illness uncertainty and how it plays a role 
in the overall perception of both alpha-1 patients and their family caregivers may be the 
key to better managing the patients and their family caregivers’ quality of life. These 
studies are useful for the current study because they are a foundation that will help to 
understand the effects on AAT-D’s uncertain challenges and how the degree of 
uncertainty may be a critical factor in how the patient and their family caregiver perceive 
the patient’s health related quality of life. 
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Coping Mechanisms of Alpha-1 Deficient Individuals 
 Coping with breathlessness is a complex and multidimensional challenge for 
people with COPD which involves interacting physiological, cognitive affective, and 
psychosocial dimensions (Jorgensen, Lombborg, Dahl, & Pedersen, 2014).  People 
suffering from COPD most often develop a variety of strategies to cope with 
breathlessness, which may either negatively or positively influence not only their 
breathing abilities but also their overall quality of life (Jorgensen et al., 2014).  The next 
few studies explored and captured the multidimensionality of how people cope during 
daily living with the COPD challenges. 
 In research conducted by Cooney et al. (2013), the authors studied how 
breathlessness influenced COPD individuals’ activities of daily living and their overall 
perception of life.  The authors found that at the initial stage of COPD, the individuals 
were able to co-exist with the COPD symptoms.  However, as the disease progressed, the 
unpredictability of it strained the co-existence and even produced an uncontrollable co-
existence depending on the degree of the breathlessness (Cooney et al., 2013).  In another 
study, the authors Sunde, Walstad, Bensten, Wagnen, Rustoen, and Henriksen, (2014) 
analyzed the possible impact of a COPD home care model has on COPD individuals and 
found that it exhibited a positive progressive attempt to integrate the competencies and 
behaviors of the patients and the community nurses to provide follow-up care in 
accordance with the guidelines for interventive care.  In turn, the authors suggested that 
the next step is to evaluate the COPD home care model’s ability to assist both healthcare 
workers and planners to improve the management of COPD, reduction of exacerbations 
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and improve the quality of life and coping among patients with COPD (Sunde et al., 
2014).  
 The impact of stress caused by a chronic disease can have consequences on daily 
functioning and quality of life.  Adaptation to a chronic illness depends not only on the 
degree of the disease but also on the individual’s capacity to evaluate and react to the 
stressors associated with the disease.  A study conducted by Hesselink et al. (2004) 
examined the association between psychosocial coping resources and coping style with 
health related quality of life (HRQoL) in asthma and COPD patients separately.  There 
were 220 recruited adult asthmatics and 53 COPD patients.  The data was collected by a 
pulmonary function test, face to face interviews, and questionnaires about psychosocial 
coping resources (self-efficacy, mastery, self-esteem, and social support), coping styles 
(avoidant, rational, and emotional) and HRQoL (Hesselink et al., 2004).  The results 
showed that there were significant associations between coping resources, coping style, 
and HRQoL in both asthmatics and COPD patients.  For example, in both asthma and 
COPD patients, a more emotional coping style was independently associated with poor 
HRQoL.  Asthmatics that exhibited a poor pulmonary function, showed less efficacy and 
mastery feelings, and a more avoidant coping style was considered independently related 
to poor HRQoL, whereas a more rational coping style was linked to poor HRQoL in 
COPD (Hesselink et al., 2004).  
Moreover, COPD patients scored lower on psychosocial coping resources, higher 
on coping scales and poorer on HRQoL compared to asthmatics.  In addition, asthmatics 
who had low confidence and less mastery showed poorer HRQoL.  The psychosocial 
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resources used among the COPD patients did not exhibit an independent association with 
HRQoL.  However, since the number of COPD patients was considered small, caution 
with the results was considered and the authors suggested that further research is needed 
in order to directly connect self-efficacy, self-esteem, and mastery to HRQoL (Hesselink 
et al., 2004).  
Furthermore, the degree of COPD patients’ symptoms may play a critical role in 
how they cope with their illness.  Thus, it is the mind body connection that may lead the 
COPD patient to react in a particular manner.  The authors, Jorgensen et al. (2014), 
conducted a grounded theory study to explore the nature of coping, specifically with 
breathlessness from 12 patients with moderate to severe COPD. In particular, the study 
examined COPD patients’ physiological and behavioral parameters that could distinguish 
between the four coping types, such as overrater, challenger, underrater, and leveler 
(Jorgensen et al., 2014).  As a result, the data exhibited a relation between the 
physiological condition and coping behavior among people with COPD living with 
breathlessness.  However, the authors suggest that the results should be tested on a new 
population involving education, social, economic, and cultural aspects within a 
longitudinal study with more participants (Jorgensen et al., 2014).  In the following 
section, studies will explore how CBT may manage the anxiety and depression levels of 
COPD patients. In the current study, I evaluated the effects of a progressive chronic long 
term illness, AAT-D, and how the uncertain challenges of the illness may place a strain 
on both the alpha-1 patients and their family caregivers’ perceptions of their quality of 
life. 
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CBT, Coping, and COPD Patients 
 Chronic disease is associated with high levels of uncertainty.  Patients need to 
change their behavior as part of a new lifestyle of self-care.  They also endure debilitating 
and demanding treatments (White, 2001).  These are a few factors that make adjustments 
to chronic illness psychologically demanding.  Previous research has found cognitive 
behavioral therapy (CBT) to be effective in managing chronic physical illness.  In 
particular, the cognitive therapy framework is suited to address the problems associated 
with chronic disease, such as mood disorder and fatigue (White, 2001).  Additionally, 
CBT has proven efficacy to promote active self-management and help patients establish 
collaborative relationships with health care staff, as well as build the skills needed to 
manage the psychological problems linked with chronic illness (White, 2001).  Thus, the 
following studies will evaluate the effectiveness of CBT has on COPD patients’ 
psychological challenges. 
 Hynninen, Bierke, Pallesen, Bakke, and Nordus (2010), examined the effect of 
CBT in groups of COPD patients of both sexes with co-morbid clinically significant 
anxiety and depression.  There were 51 participants and the main outcome measures were 
comprised of the Beck Anxiety Inventory and Beck Depression Inventoryn11.  Measures 
of health status, sleep, age, and sex were also included as secondary outcomes (Hynninen 
et al., 2010).  The findings indicated that CBT may provide rapid symptom relief for 
COPD patients with clinically significant anxiety and depression.  However, women 
exhibited higher anxiety and depression levels with non-significant improvements with 
the aid of CBT compared to males.  In addition, the younger patients appeared to have 
35 
 
more anxiety and depression compared to the older participants.  However, both 
responded well to CBT (Hynninen et al., 2010).  Poor sleep patterns revealed non-
significant improvements with the use of CBT.  Thus, COPD patients may reflect 
feelings and fatigue during the day as a consequence of the lung disease and possible 
reduced sleep quantity caused by breathlessness (Hynninen et al., 2010).  
Some studies have examined the psychological needs of COPD patients.  COPD 
patients experience disabling physical symptoms, such as breathlessness, chronic cough, 
and sputum production, a large proportion of patients also experience psychological 
distress (Baraniak & Sheffield, 2011).  In particular, anxiety and depression may become 
prevalent.  A systematic review and meta-analysis have reported that clinical anxiety and 
depression account approximately for 36%-40% of COPD patients which significantly 
shows a reduction in the patients’ quality of life (Baraniak & Sheffield, 2011).  A study 
was performed to evaluate the efficacy of psychologically based interventions, such as 
cognitive behavioral therapy, psychotherapy, and a progressive muscle relaxation for 
patients who struggle with COPD.  The study was predominately comprised of COPD 
patients with moderate to severe disease that experience existing morbidity of mild to 
moderate anxiety and/or depression (Baraniak & Sheffield, 2011).  The authors suggested 
that the interventions did not appear to be effective in reducing psychological morbidity 
in COPD population (Baraniak & Sheffield, 2011).   
Due to the chronic and progressive character to the disease, patients are not only 
physically limited but often show reductions in both their psychological and social 
functioning which can feedback on the course of the disease, as well as on the social 
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environment (Leupoldt, Fritzsche, Truebu, Meuret,  Ritz, 2012).  Previous studies have 
analyzed psychotropic medications but the evidence to support COPD patients’ 
psychological needs has been weak.  
Leupoldt et al. (2012) examined a few studies which provided an overview on 
findings on psychosocial factors and behavioral medical approaches and found that CBT 
to be beneficial for COPD patients.  Specifically, aspects including behavioral activation, 
enhancement of competency through skill building exercise, cognitive re-structuring, 
psychoeducation, problem solving techniques, sleep management skills, self-instruction 
training, and stress management have also exhibited positive outcomes as additives to the 
CBT (Leupoldt et al., 2012).  The use of relaxation techniques, like yoga have revealed 
beneficial effects to calm the breathlessness of COPD patients.  In addition, in a few 
smaller studies, biofeedback training has suggested some potential effects to oxygen 
saturation and ventilation patterns.  Attentional distraction has been proposed as useful in 
reducing the preserved level of exertional dyspnea.  However, studies specific to COPD 
patients have shown to be conflicting (Leupoldt et al., 2012).  Other studies recommend 
that there may be a link between COPD patients’ physiological and behavioral pathways.  
Although beneficial effects of some behavioral medical intervention has been 
demonstrated in COPD, future research is suggested to study the effects of distinct 
components of these interventions as a goal to link the importance of the psychological 
and sociological aspects to COPD patients’ quality of life (Leupoldt et al., 2012).  
 The most common physical symptoms of COPD patients are breathlessness, 
cough, and excessive sputum production.  However, additional physical consequences, 
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such as systematic inflammation, nutritional challenges, musculoskeletal dysfunction, 
fatigue, low activity, and poor exercise capacity may occur which will often lead to 
psychological distress (Farver-Vestergaard & Zachariae, 2015).  Thus, throughout 
literature, it is suggested that the physical and psychological effects of the disease work 
synergistically together which catalyzes the exacerbation rates of the physical and 
psychological symptoms in a continuum (Farver-Vestergauard & Zachariae, 2015).  In 
turn, psychosocial research has been conducted in an attempt to discover a positive 
supplement to medical and physical treatment for COPD patients.  
Farver-Vestergaurd and Zachariae (2015) conducted a systematic review and a 
meta-analysis of controlled trials that evaluated the effects of psychosocial interventions 
on psychological and physical outcome of 1,361 COPD patients.  The results revealed 
statistically significant effects of psychosocial interventions on both physical and 
psychological outcomes in COPD patients when compared with passive or active control 
groups (Farver-Vesterguard & Zachariae, 2015).  Regarding the effects of the different 
types of psychosocial intervention being used with COPD patients, the moderation 
analyses showed that only CBT significantly increased psychological outcomes and the 
mind-body intervention significantly increased the physical outcomes (Farver-
Vestergaurd & Zachariae, 2015).  On the other hand, duration of the treatments exhibited 
an insignificant effect on the patients’ physical and psychological outcomes.  For 
example, the data exhibited non-significant results for both CBT and mind-body 
intervention on physical and psychological outcomes.  The authors propose one 
explanation could be the deteriorating effects of the COPD patients’ physical and 
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psychological condition over time.  Therefore, the authors recommend to further examine 
the most appropriate duration time of treatment.  In the current study, I analyzed the 
coping strategies of AAT-D patients and evaluated the common themes that have a 
critical role in impacting the patient’s quality of life.  
Age and Diagnosis of AAT-D- Associated COPD 
 Studies have found that age plays a role in how COPD patients manage their 
disease.  A study conducted by Holin, Plautcan, Ford, Sandhaus, Strand, Strange, and 
Wamboldt, (2014) examined the impact of age on both the psychological and clinical 
outcomes among individuals with AATD-associated COPD.   There were 468 individuals 
with AATD ages 32-84 that completed questionnaires at baseline and then at one and two 
year follow-up.  Age was examined as a predictor of depression, anxiety, and health 
related quality of life, and breathlessness at all three time points using linear mixed 
models (Holin et al., 2014).  The authors indicated that younger individuals reported 
more symptoms of anxiety over a two year period, regardless of relationship status.  On 
the other hand, younger individuals reported more symptoms of depression, worse health 
related quality of life, and more breathlessness only if they were single.  Thus, age was 
not associated with depression, health related quality of life, or breathlessness among 
individuals who were in a couple relationship (Holin et al., 2014).  
The authors suggested that being in a relationship may be an important social 
resource for younger individuals with AATD- associated COPD.  Hence, being married 
positively influences psychological distress and future studies may strive to analyze other 
social resources, such as the relationships with family and friends as additional systems 
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that may play a role in one’s psychological and health related quality of life (Holin et al., 
2014). 
There is evidence suggesting that psychosocial resources in the form of social 
support may play an important role in managing and slowing of the progression of a 
variety of chronic degenerative diseases.  In persons with COPD, receiving positive 
social support, interaction from spouse/partner, friend, extended family, and/or support 
group may be associated with reduced hospitalizations, better health status and 
promotion, disease management behavior, and engaging in physical exercise (DiNicola, 
Jilian, Gregorich, Blanco,  Katz, 2013).  Moreover, previous research has posited that the 
quality of the relationship may have an impact on the overall quality of life of the COPD 
patient (DiNicola et al., 2013).  
DiNicola et al. (2013) examined the contribution of perceived social support to 
the presence of anxiety in persons with COPD.  A sample of 452 COPD participants 
completed telephone surveys.  Thus, the study used a cross-sectional design which 
measures included the anxiety subscale of the Hospital Anxiety and Depression Scale, 
five social support subscales from a positive and negative social exchange scale, a COPD 
Survey Scale, and the Geriatric Depression Scale (DiNicola et al., 2013).  Positive and 
negative social support were defined as positive and negative social interactions.  Both 
positive and negative aspects of social support emerged as significant and independent 
predictors of patient anxiety.  
Two negative aspects of social support, the perceived use of insensitive and 
unsympathetic responses by social networks, were associated with greater anxiety in 
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COPD patients, whereas, stronger support from social networks exhibited fewer 
depressive symptoms (DiNiCola et al., 2013).  On the other hand, practical help received 
from others increased patients’ anxiety by making salient their needs and dependence of 
others.  However, other factors such as the type of relationship (spouse, friend, extended 
family member, or co-worker) and quality of relationship were not evaluated within the 
study.  The authors suggested that the type and quality of the relationship may have an 
influential factor for COPD patients (DiNiCola et al., 2013). Although the study provided 
an association between greater support with decreased depression and less support with 
greater depression, the relationship between depression and anxiety in chronic lung 
disease remains unclear (DiNiCola et al., 2013).  Even though I did not specifically  
examine how age plays a role in the AAT-D patient’s perception of life, these studies 
provided an insight into the timing of being diagnosed with a long term illness and how it 
affects a patient’s perception of quality of life. 
Family Caregivers 
 Family caregivers take on an important role with little to no training and with 
limited resources.  They are required to provide a broad range of assistance which 
includes monitoring and managing the treatment and symptoms of the disease, 
medication administration, emotional support, as well as assistance with personal care 
and financial support (Rha et al., 2015). Caregiving burden is described as the distress 
that caregivers feel as the result of proving care.  It is specific to the complexity and 
degree of the disease care and varies from anxiety and depression to other emotional and 
more general responses.  Caregiving burden encompasses physical burden, such as sleep 
41 
 
disturbances, fatigue and pain (Rha et al., 2015).  The emotional support provided by the 
caregiver to the chronically ill patient is considered as difficult psychological tasks.  
Moreover, missing work because of the caregiving responsibility and caring for others 
besides the chronically ill patient could be considered a social burden.  The financial 
burden could be consequent from paying high medical expenses and losing income and 
savings (Rha et al., 2015).  The following studies exhibited the challenges family 
caregivers face taking care of chronically ill patients, such as cancer, COPD, and AAT-D.  
 
Family Caregivers and Cancer Patients 
 Family caregivers play a critical role in caregiving. In particular, family 
caregivers (FCs) of people with cancer often feel overwhelmed as a result of the intense 
responsibility associated with managing the patient’s symptoms, providing them with 
emotional support, and assisting in various care related tasks (Lee et al., 2015).  In turn, 
the high demand of care may increase the risk of the caregiver’s physical and emotional 
decline, as well as the challenges placed on their social and financial status.  Sleep 
problems commonly impact the physical and mental health of FCs. Previous studies have 
shown that between 45% and 95% of caregivers report mild to severe sleep disturbances 
(Lee et al., 2015). 
Lee et al. (2015), suggests that sleep disturbances of perceived or actual alteration 
of sleep patterns.  The criteria for sleep disturbance include sleeping for less than seven 
hours, sleep latency of more than 20 minutes, waking up more than six times per night, 
napping for more than two hours, and sleep efficacy of less than 80%. Lee et al. (2015) 
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conducted a study to assess sleep disturbance using both subjective and objective 
measures.  There were 238 FCs of terminally ill cancer patients who initially participated 
and a total of 176 FCs who completed the study.  The results showed that caregivers of 
patients with advanced cancer had more sleep disturbances compared to those caregivers 
of patients in the earlier stages of cancer (Lee et al., 2015).  
This study provides an insight into the complexity of the challenges family 
caregivers face while caring for the chronically ill and will help me focus my study on the 
family caregiver’s stressors of the physical (sleep disturbances), emotional (caring for a 
loved one), and the social (isolation from the outside world) and financial (high expenses 
and fewer hours at work) obstacles on a daily basis.  
Family Caregivers and COPD Patients 
 Severe and progressive dyspnea is one of the most debilitating and frequent 
complaints of patients with COPD.  Thus, pervasive dyspnea can be frightening to both 
the patient and the caregiver which can lead to high stress levels (Lee et al., 2010).  
COPD can result in physical disability, altered cognition and memory disturbances due to 
the lack of oxygen to the brain, as well as behavioral changes that may further increase 
the demand of care for caregivers.  Besides the increased care for the physical symptoms 
of the patient, caregivers also have to be their decision maker, financial manager, deal 
with the patient’s attitudes and irritability, and assist with their activities of daily living 
(Lee et al., 2010).  
Lee et al. (2010) conducted a study to examine the health related quality of life 
and burden of caregivers of patients with COPD and to identify associated relevant 
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factors.  The study involved 81 eligible Chinese caregivers who completed a caregiver 
survey on HRQOL, caregiving burden, and other biopsychosocial factors.  The results 
suggested that the psychosocial well-being of caregivers was associated with their 
physical health, anxiety and depression levels, and social support.  In particular, 
emotional distress was exhibited in COPD caregivers with little to no support or 
assistance (Lee et al., 2010).  Thus, those caregivers who experienced a low level of daily 
emotional support perceived caregiving in a more negative manner which lead to 
depression over time (Lee et al., 2010).  This study provides an in-depth view from a 
caregiver’s perspective on caregiving to COPD patients and how the emotional and social 
support may be as important to the caregiver as the COPD patient.  It was useful to my 
study because it helped me focus on the experiences of the caregiver which I may build 
upon to understand the needs of the caregiver to AAT-D patients.   
Family Caregivers and Coping With COPD Patients 
The demands of COPD can place a significant burden on family members.  COPD 
is an incapacitating disease which progresses, and the exacerbations and comorbidities of 
the disease severely affect the patients’ physical and social dimensions of life 
(Jacomeedo, Gabriel, Cruz, & Marques, 2014).  The gradual disability experienced by 
patients contributes toward the dependence on family assistance which becomes the 
central and support.  In turn, the increased demand on the family caregiver develops into 
elevated levels of stress (Jacome et al., 2014).  
Jacome et al. (2014) examined the psychological health of family caregivers and 
patients with COPD.  The main findings suggested that family caregivers presented 
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clinically significant anxiety and depressive symptoms, their perceived burden, female 
gender, older age, and patients’ activity limitations were significant predictors of their 
distressing symptoms.  The results also indicated that female caregivers had statistically 
significant higher levels of anxiety and depression than male caregivers (Jacome et al., 
2014).  However, no statistically significant differences were found for both anxiety and 
depression considering the quality of relationship between the family caregiver and the 
COPD patient.  There was a statistically significance in depression among the family 
caregivers who cared for patients with advanced COPD compared to those patients who 
were in the early stages of COPD (Jacome et al., 2014).  On the other hand, anxiety 
showed no statistically significance among family caregivers of either early stages of 
COPD or advanced stages of COPD (Jacome et al., 2014).  
Lee et al. (2010) examined HRQOL and the burden of COPD caregivers and to 
identify the relevant factors associated with the burden of care.  The study included a 
total of 81 caregivers that completed a caregiver survey on HRQOL, caregiving burden, 
and other biopsychosocial factors.  Descriptive statistics, correlations, and multiple linear 
regression models were used to analyze the data.  The authors suggested that the 
psychological well-being of caregivers was associated with their physical health, anxiety 
symptoms, and social support. Emotional distress was encountered in COPD caregivers 
with little or no support and assistance (Lee et al., 2010).  However, there were some 
limitations to the study. For instance, the cross-sectional study may not reveal the effect 
on the caregiving burden and caregivers’ QOL (Lee et al., 2010).  Additionally, the use of 
only Chinese participants may not be representative of the majority of COPD caregivers.  
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Thus, cultural perspectives may play a role in how they share their feelings and 
communicate with each other.  
Caring for a family member with a progressive chronic disease like COPD can 
put a strain on finances.  Not only are there high costs for the traditional medical 
treatments on a daily basis but also on the family’s personal finances.  Hence, the cost of 
the electrical bill may be high due to the oxygen therapies and lowered air conditioning 
temperatures needed to make the COPD patient more comfortable.  Additionally, the loss 
of work hours from both the patient and family caregiver places a strain on the family’s 
income.  Research shows in the United States, individuals with COPD receive an 
additional 5.1 hours a week of informal care compared to those without lung disease 
which represents an annual cost of $2 billion dollars (Figueiredo et al., 2014).  Thus, 
these numbers indicate that the family caregivers provide a vital source of care to their 
relatives.  As a result, the combination of the increased demands on finances and caring 
for a loved one impacts the caregivers’ psychological well-being (Figueiredo et al., 
2014).  
As an example, Figueiredo et al. (2014), conducted a study to analyze the 
subjective burden of family caregivers of people with early and advanced COPD.  The 
study was from a cross-sectional perspective, involving a total of 167 family caregiver 
with 113 caring for people with early COPD and 54 caring for those COPD patients with 
advanced stage.  The authors suggest that family caregivers of people with advanced 
COPD experienced more stress compared to those caring for early stages of COPD.  
Caregivers of advanced COPD also reported higher depression and a worse self-rated 
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mental health compared to their counterparts (Figueiredo et al., 2014).  Moreover, COPD 
severity was found to be a significant predictor of the caregivers’ subjective burden, as 
well as the hours per week spent on caregiving tasks.  The frequency of anxiety 
symptoms was found to be similar in both groups, underlying the uncertainty and 
unpredictable nature of the disease (Figueiredo et al., 2014).  Furthermore, significant 
correlations among financial consequences, anxiety and depression scores, and self-rated 
health were discovered, positing the stressful entity of financial implications of COPD.  
The authors propose that the financial strain is mainly related to expensive medication, 
oxygen therapy, along with the loss of the care recipient’s income due to early retirement 
forced by the disease (Figueiredo et al., 2014).  In the current study, I examined the 
stresses of everyday life for the family caregivers, such as the physical and emotional 
strains on watching and taking care of their loved ones with AAT-D, as well as the 
financial and social struggles they face daily.  In addition, I evaluated the coping 
strategies of the family caregivers and examined the common coping strategy that 
manages their stresses daily.  
Family Caregivers (Spouses) and COPD 
 Patients experience and deal with changes caused by the disease and its treatment, 
as they do with the increasing dependence on others.  Thus, individuals with COPD have 
to cope with social, practical, and existential challenges that affect the well-being of both 
themselves and their relatives.  Living with a person who suffers from COPD has both a 
physical and mental impact (Ek, Ternestedt, Andershed, & Sahlberg- Blom, 2011).  
Previous research has suggested that family caregivers suffer from fatigue and live in 
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constant fear of the ill person’s impending death. Ek et al. (2011) conducted a study to 
examine couples who experience living together with a partner who has advanced COPD.  
The study involved four couple over an eight month period using repeated qualitative 
interviews.  As a result, Ek et al. (2011) suggested that the phenomenon of living as a 
couple when one partner has advanced COPD was found to consist of one main theme, 
living with the disease and one’s spouse is a new changeable life rhythm.  In particular, 
the underlying common denominators were uncertainty, living with a changed intimate 
relationship (less physical intimacy), and finding new ways of living together.  These 
studies provide background information to further analyze the perceptions of the family 
caregivers, such as spouses and children.  In particular, how each of the family caregivers 
manage not only their physical and mental health but also their family member struggling 
with AAT-D.  
Family Caregivers (Spouses), AAT-D, and Communication 
 Both spouses exhibit similar beliefs, attitudes, and behaviors which are often 
exposed to the same experiences.  For instance, a couple may receive the news that their 
partner has been diagnosed with alpha-1 deficiency and share the same negative feelings 
(Smith, et al., 2014).   Thus, it is a synergistic effect of feelings and emotions on a daily 
basis.   However, spouses may talk with each other to cope with their shared reactions 
which may lead to altered stress levels.  
 Smith et al. (2014) conducted a study to examine the intrapersonal and 
interpersonal influences in 50 couples. Their findings suggested as the couples felt more 
negative emotions about AAT-D, there were increasingly higher levels of stress. 
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Additionally, for spouses, communication about AAT-D and stress were positively 
related.   Those who tested positive for AAT-D identified their spouses as their primary 
source of support.  However, spouses may be stressed because they may not feel that they 
are being supportive enough or they may suppress their own personal worries and 
uncertainty of the illness which creates heightened stress for the spouses.  In turn, Smith 
et al. (2014) suggest that the spouses may need assistance in communicating their own 
feelings.  Moreover, the data indicated that patients with AAT-D communicated more 
about their feelings and emotions on the challenges they face with their disease with their 
spouse who felt less social and family isolation stigma as compared to spouses who 
perceived a stronger sense of social and family isolation stigma.  Smith et al.’s study 
provides the current study additional information on how important open communication 
of feelings and emotions are to the management of the fear and uncertainty levels brought 
on by the challenges of AAT-D.  In the current study, communication between the AAT-
D individual and their family caretaker (spouse) showed as one of the key elements that 
helps both the AAT-D individual and their caretaker cope with the stresses of the 
complexity and uncertainty of the illness.   
Summary 
` AAT-D is a genetic disorder with a high risk factor for the development of 
COPD, affecting most commonly the white population (de Serres et al., 2003).  AAT-D is 
often undetected or misdiagnosed, taking an average of seven to eight years after 
symptoms develop to be properly diagnosed (Campos et al., 2005).  In addition, the 
uncertainty and complexity of COPD has shown to be stressful for not only the patient 
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but also their family caregiver (Stenzel et al., 2015).  Moreover, previous research has 
shown that the interaction between the COPD patient and their family caregiver has an 
altering result in how they cope with the disease’s physical and psychological demands 
on a daily basis (Barnett, 2004; de Voogd et al., 2011; Figuerido et al., 2014., Hoth et al., 
2015). 
 What is not known, however, is the complexity of AAT-D associated COPD and 
the disease’s specific anxieties that are placed on both the alpha-1 deficient patient and 
their family caregiver.  The current research examined and determined the challenges of 
proper diagnosis.  For example, what are the most common coping strategies used across 
the alpha community that helps both the alpha-1 patient and their family caregiver 
manage the stressors on a daily basis?  Is there one specific coping mechanism or a 
combination of factors that influences the patient’s and their caregiver’s overall 
management of the illness, as well as the caregiver’s daily personal and social aspects?  
Chapter 3 provides information on how this study was performed, how the participants 
were  identified, the questions that were asked, and how the information was organized 
and analyzed.  
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Chapter 3: Research Method 
Introduction 
In Chapters 1 and 2 I discussed how AAT-D is a genetic disorder that is a high-
risk factor for developing COPD, which most commonly impacts the European White 
population (de Serres et al., 2003).  In addition, I described the high rate of undetected or 
misdiagnosed AAT-D (Campos et al., 2005).  Moreover, I reviewed research indicating 
that the uncertainty and complexity of COPD is stressful for both the AAT-D patient and 
their patient’s family caregiver (Barnett, 2004; de Voogd et al., 2011; Figuerido et al., 
2014; Hoth et al., 2015; Stenzel et al., 2015).   
   The reviewed research also highlights, the importance of the interaction 
between the COPD patient and the patient’s family caregiver on how both parties cope 
with the disease’s demands (Barnett, 2004; de Voogd et al., 2011; Figuerido et al., 2014; 
Hoth et al., 2015; Stenzel et al., 2015).   
As I noted, what is not known, however, is the complexity of AAT-D-associated 
COPD and the specific anxieties that are of both the alpha-1 deficient patient and the 
patient’s family caregiver.  Understanding the experiences of both the AAT-D patient and 
the patient’s family caregiver and discovering the most common coping strategies used 
by the AAT-D patient and the patient’s family caregiver may bring forth a deeper insight 
into the daily challenges faced by patients and family caregivers.  In this chapter I outline 
the qualitative method I used in the study and present the research questions, 
methodology, design, as well as the overall data analysis.   
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Research Design and Rationale 
Research Questions 
RQ1. How do AAT-D patients describe living with their illness? 
RQ2. How do the family caregivers who live with AAT-D patients describe their 
experiences? 
RQ3. What are the common coping strategies among AAT-D patients? 
RQ4. What are the common coping strategies among the family caregivers? 
Research Methodology and Rationale 
I used qualitative methodology for the study.  Previous researchers appeared to 
have focused on the challenges COPD patients face on a daily basis, as well as how the 
severity of their symptoms may impact their health-related quality of life.  In addition, 
researchers have focused on how COPD patients’ caregivers may manage the daily 
challenges from psychological and physical perspectives.  In contrast, I examined the 
specific complexities of AAT-D associated-COPD and explored AAT-D patients’ 
experiences and coping strategies in conjunction with their family caregiver’s 
experiences and coping strategies.  Selection criteria for the eight AAT-D patient 
participants were that they had be diagnosed between the ages of 20 and 50 years old and 
did not currently smoke, so other confounding factors can be eliminated.  The family 
caregiver who was chosen was considered to be the primary caregiver, which could be a 
spouse, child, or sibling of the AAT-D patient.   
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Research Design and Rationale 
I chose phenomenology as the research design to examine the experiences of 
AAT-D patients and family caregivers.  I conducted a phenomenological inquiry to 
reveal unified experiences across the same population and described  a phenomenon that 
exists in people’s minds that is most appropriately explained through the perspective of 
those who have faced similar experiences (Barken, Thygensen, &  Soderhamn, 2018; 
Creswell, 2014).  Some previous researchers have incorporated a phenomenological 
approach to better understand the lived experiences of COPD patients.  Barken et al. 
(2018), for instance sought to describe the quality of life among patients challenged with 
COPD; the researchers included participants in a telemedical intervention after 
hospitalization from their disease exacerbation.  The findings showed that telemedical 
intervention can reduce the perceived limitations of living with COPD by eliciting 
support from health professionals, strengthening clinical insight, and developing a mutual 
clinical language that may help keep clear and open communication channels between 
patients and health professionals (Barken et al., 2018).  For this reason, I selected a 
phenomenological approach to examine the lived experiences of both the family 
caregiver and the caregiver’s and AAT-D family member. 
Role of the Researcher 
I observed the participants’ behaviors while conducting interviews.   I conducted 
16 total interviews, one interview for each of the eight AAT-D patients and one interview 
for each of the eight family caregivers.  There were no personal or professional 
relationships between the AAT-D patients or family caregivers and me.  However, a few 
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of my family were members of the Alpha-1 Association and were precluded from 
participating in the study.  To help limit possible bias in the research, I approached the 
participants neutrally, without personal bias, and kept a journal where I related any 
emotions I experienced during the interview process.  Moreover, I was not engaged in 
social conversations or shared personal experiences about AAT-D with the participants 
during the entire study.  I also provided nonleading interview questions.  The participants 
chose the most appropriate and comfortable environment in which to be interviewed.  If 
the participants began to experience physical and/or emotional challenges during the 
interview process, they were free to leave the study and reconvene at a later time.  Notes 
were provided and/or adjusted within the results.  
Methodology 
Participant Selection Logic 
I interviewed 16 total individuals, of whom eight were AAT-D patients and eight 
were family caregivers.  I selected participants using purposive sampling.  The AAT-D 
participants were diagnosed with AAT-D between the ages of 20 to 50 years old and did 
not report smoking at the time of the study.  The AAT-D patient’s caregiver was a 
spouse, child, or sibling who was the primary caregiver.  Participants were recruited 
through Facebook and/or e-mails within the Alpha community that lived in the southern 
part of the United States.  Discussing the study with alpha-1 community members helped 
me to identify AAT-D patients and their family caregivers who might participate in the 
study. I used Facebook and/or e-mail to contact interested participants to confirm study 
participation and begin the interview process.  A letter describing the study was sent to 
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the Alpha-1 community and potential volunteers.  This letter can be found in Appendix 
A.   
Instrumentation 
The purpose of this study was to examine the daily experiences of AAT-D 
patients and their family caregivers face.  In addition, I analyzed coping strategies among 
both AAT-D patients and their family caregivers.  The goal was to discover the most 
common coping strategies used among AAT-D patients and their family caregivers helps 
to manage daily stressors.  I posed four broad research questions (see Chapter 1) to better 
understand participants’ experiences.  The study involved one interview administered to 
each AAT-D patient and one interview to each family caregiver. Each interview focused 
on the participant’s life history and encompassed the participant’s detailed reflection on 
his or her experiences.  However, if a participant indicated being overwhelmed, either 
physically or emotionally, I stopped the interview process and finished it at another time 
when the participant was ready to continue.  Specific interview questions are listed in 
Appendix B. 
Procedures for Recruitment, Participation, and Data Collection 
 The following procedure served as a sequential guide to recruit and inform 
participants, collect, and analyze data, and validate findings.  Contact was made via 
telephone to the person in charge of the National Foundation of Alphas to provide 
information about the study to the alpha community. An informative letter detailing the 
nature of the study was sent to the person in charge of the National Foundation of alphas, 
requesting assistance in recruiting the participant.  An additional letter was sent to the 
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Alpha-1 community requesting permission to recruit and conduct the study using the 
community members.   Advertising the nature of the study was through the Alpha-1 
community Facebook page, emails, and phone.  Thus, any male and female AAT-D 
patients and their family caregivers who were interested in participating in the study was 
informed to contact the researcher to schedule an initial interview and a follow-up 
telephone call was made if there is not contact within one week of informative meeting.   
 During the individual interviews, each participant was given a copy of the letter 
describing the proposed study and signed the Consent Form.  The interview included 
asking questions listed throughout the interview in Appendix B.  After the interviews 
were completed, the audiotapes were transcribed verbatim and analyzed according to the 
steps at the end of the chapter.  The interviews were conducted in an individual format to 
provide further validation that the results depict their experiences. 
Data collection. Data was collected through an interview process.   The interview 
focused on the background of the participant with the intent to put the participant’s 
experience in context.  This interview involved building a rapport, signing the consent 
form, and gathering information about the individual’s life up to the present time.  
Stadtlander (2015) recommended placing the participant’s experience in the context of 
the topic.  Information gathered during the first interview provided insight into the 
complexity of AAT-D and how it has impacted the AAT-D patient and their family 
caregiver from the time of diagnosis to the present time.  The interview also entailed 
describing the nature of the study and shared the researcher’s personal experiences 
related to AAT-D.  The purpose of sharing this information assisted in building a rapport 
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with the participants.   
The interview also addressed the details of the participant’s present experience by 
asking focused questions that stem from the research questions in the study. You may 
view the interview questions in Appendix B.   
To address the third and fourth research questions, each AAT-D participant was 
asked to describe specific coping strategies that they feel helps them manage both their 
physical and psychological state on a daily basis most efficiently and how often they 
engage in these coping strategies.  Each question for the interview process is listed in 
Appendix B.   
Lastly, the interview entailed having the participants describe the meaning of their 
experience as being an AAT-D diagnosed patient or the sole family caregiver to these 
family members.  Additionally, the questions served to validate the overall meaning for 
the group of participants discovered during the analysis of data.  The interviews were 
conducted in a location selected by the participant that is free from distraction and 
ensures privacy.  Each interview was tape recorded and transcribed.  Additionally, notes 
were taken to document nonverbal communication and provide details of the 
environment.   
Data was organized by creating files of the transcribed interviews.  Files and 
recordings were maintained in a locked filing cabinet in the researcher’s home office.  
Once the data was transcribed the process of analyzing the information began. 
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Data Analysis Plan 
Once the data was organized, I obtained an overall understanding of what type of 
information the data is providing.  The goal of the first step was to begin to understand 
what type of information the data is conveying.  The second step was to begin 
highlighting the statements in the text that have specific meaning and importance to the 
phenomenon being studied.   In this case, the proposed research attempted to extract 
statements to understand the complexity of AAT-D, how it impacts both AAT-D patients 
and their family caregivers, and if there is one or a combination of coping strategies that 
best manages the stressors exhibited by AAT-D patients and their family caregivers on a 
daily basis.  Each presented experience helped bring forth the necessary variables that 
have the potential to be labeled.  Thus, the most influential factors to the participants’ 
experiences were necessary to understand and those factors that were not considered an 
impact was eliminated.  Labeling the statements identified as necessary to understanding 
the phenomenon was the third step in understanding both AAT-D patient and their family 
caregivers’ challenges experienced daily.   
For the proposed study, I began labeling the underlying meaning factors in the 
form of physically and psychologically sensitive expressions.  These expressions 
represented the physical demands, feelings, emotions, and actions concerning how the 
participants have and continue to experience the phenomenon.  The statements were 
reframed by using meanings to describe the everyday ordinary language concerning the 
phenomenon.  The final step analyzed the data involved in developing the individual and 
then group descriptions of the experience.  Constructed what it meant for each participant 
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to experience the challenges presented by AAT-D and then connected each participant 
(AAT-D patients and family caregivers) to the experience that helped explain the essence 
of the phenomenon as a family unit. 
Issues of Trustworthiness 
The purposed research findings verified, which is common in qualitative studies.  
Morse, Barnett, Mayan, Olson, and Spiers (2002), posits that the use of verification 
strategies helps to ensure the reliability and validity within a qualitative study.  The 
purposed research employed triangulation to help ensure credibility and the use of rick, 
thick descriptions to convey the findings which employed the appropriate strategies to 
establish transferability.  Creswell (2014) recommends that triangulation will help build a 
cohesive justification of themes and if themes are found throughout the study based upon 
the perspective from the participants, then validity to the study has been increased.  Thus, 
one of the goals for the purposed study was to discover the most common and beneficial 
coping strategies used across both the AAT-D patients and their family caregivers that 
helps manage their stressors most optimally daily.  
Moreover, the use of rich, thick description across the detailed shared experiences 
from the challenges of AAT-D among both the AAT-D patients and their family 
caregivers helped add to the validity of the findings and conveyed the results more 
realistically (Creswell, 2014).  The proposed study had verbatim transcripts that provided 
contextual and descriptive information.  There were process notes in the margins of the 
transcript that highlighted the meaning and directed quotes from participants beneath 
physical and psychological expression.  Each of the aforementioned method of analysis 
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was important in providing a rick, thick description.  Moreover, dependability and 
confirmability was accomplished through audit trails.  For instance, I kept a detailed 
written record of everything done in the study, whom I met with, and the specific topics 
that were discussed.  Thus, the transcribed verbatim transcripts and the additional detailed 
notes about the conducted study and surrounding environment, whom I met with, and the 
degree of the explained results from the data collected helped decrease the level of biased 
research, increasing the connection between the findings and the focus of the study. 
Ethical Procedures 
 The participants in the study were adult male and female volunteers who were 
free to choose whether to participate.  There was no known harm associated with 
participating in this study.  If a participant experienced harm or difficulty associated with 
participating in this study, a referral to local services was made.  If any participants felt 
any emotional distress from the questions presented in the study, a number for the hotline 
or the genetic counseling center provided by the Alpha-1 community was provided.  Each 
member completed a consent form and confidentiality was protected.  Files, audiotapes, 
and transcripts were stored in a locked cabinet in the researcher’s home office.  Only the 
researcher and those selected to assist in validating results had access to the transcripts.  
All the data was maintained on a password protected flash drive and/or hard drive with 
limited access to the information.  Identifying information was removed from transcripts 
prior to data validation and all data will be destroyed after five years.   
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Summary 
 The current study examined the complexity of AAT-D and how it impacts both 
the AAT-D patients and their family caregivers on a daily basis.  In particular, the 
analysis involved a qualitative approach with a phenomenological design as a goal to 
gain a deeper insight into the personal experiences of the AAT-D patients and their 
family caregivers.  Moreover, one interview per participant was conducted while 
maintaining ethical procedures and established reliable and valid pertinent data to the 
study.  Chapter 4 will provide information describing the location of the study, how often 
I met with the participants and the length of time both for the individual interviews, as 
well as for the total study.  In addition, how I recorded and transcribed the interviews will 
be explained.  Moreover, the details on how I analyzed the qualitative data will be 
exhibited.  Lastly, I will describe how I implemented the strategies and plans discussed in 
Chapter 3. 
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Chapter 4: Results 
Introduction 
There is little previous research about the lived experiences of Alpha-1 patients 
and their primary caregiver and how both parties cope in their daily lives, according to 
my review of the literature.  My aim in the current study was to examine the experiences 
of being an alpha-1 patient and a family caregiver for someone living with alpha-1 
deficiency.  In addition, I sought to examine AAT-D patients and caregivers’ coping 
strategies.   I used a descriptive phenomenological method which gave me the 
opportunity to examine each participant’s experiences as a whole while maintaining the 
participant’s perspectives.  The individual interviews were informed by the research 
questions that I developed and used to gather the necessary data.  Chapter 4 includes a 
detailed description of the study, the setting, and the participants’ demographic 
information.  The chapter also includes an overview of the data collection and data 
analysis procedures, evidence, trustworthiness, and the study results.  I conclude Chapter 
4 with a summary of key points made in the chapter.   
Setting 
I conducted the study with 16 participants, of whom eight were alpha-1 deficient 
patients and eight were primary caregivers from the southern part of the United States.  
All the alpha-1 participants met the study’s requirements of having been diagnosed with 
Alpha-1 deficiency and not currently smoking all the caregivers met the study’s 
requirements of being the primary caregiver for the Alpha-1 deficient patient.  I contacted 
K. Erickson (personal communication, March 14, 2018), who is the associate director of 
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the Alpha-1 Foundation, via telephone to explain the study and ask for her assistance in 
sending out e-mails to the alpha-1 community.  Participants who were interested in my 
study contacted me via e-mail.  I e-mailed the interested participants the informed 
consent and scheduled a time and day to conduct the interviews. The prospective 
participants signed and sent back the informed consent.   
After receiving the informed consent form, the prospective study participants 
detailed information about the study and the steps I would take to conduct the interview.  
All prospective participants gave consent.  The interviews were conducted over the phone 
and recorded. Neither during nor after the completion of the interview did any of the 
participants appear to be distressed. The interviews lasted 30 to 60 minutes, and there 
were no apparent problems.   I did not conduct a pilot study. After the interviews, I 
transcribed and typed the interviews.  Once the interviews were completed, I thoroughly 
reviewed the interview transcripts and encrypted them.  I e-mailed them to my 
dissertation chair, Dr. Stadtlander, to review the accuracy of the typed transcripts.  I kept 
each participant’s information confidential by using an identification code for each 
participant and securing data.   
Demographics 
All eight alpha-1 participants were diagnosed with a specific genetic code of 
Alpha-1 deficiency and used various medications to help them manage their symptoms. 
They reported that they did not currently smoke.  Additionally, the eight primary 
caregivers in the study were either the patient’s spouse or significant other who primarily 
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cared for the alpha.  Table 1 displays the demographic information for each of the alpha-1 
participants. 
Table 1 
Main Study Demographics 
Participant Genetic code Medications Counseling 
AAT-D 1 SZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
AAT-D 3 ZZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
AAT-D 5 ZZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
AAT-D 8 ZZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
AAT-D 9 ZZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
AAT-D 11 ZZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
AAT-D 13 ZZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
AAT-D 15 ZZ Weekly infusions, 
oxygen, and 
nebulizers 
None 
 
Table 2 displays the demographic information for each of the primary caregivers. 
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Table 2 
Primary Caregiver Demographics 
Participant Relationship to alpha 
participant 
Counseling 
Caregiver 2 Wife None 
Caregiver 4 Wife None 
Caregiver 6 Husband None 
Caregiver 8 Husband None 
Caregiver 10 Husband None 
Caregiver 12 Husband None 
Caregiver 14 Husband None 
Caregiver 16 Wife None 
 
Data Collection 
The study began after I received approval from Walden University’s Institutional 
Review Board (approval #0124061), and I completed data collection in October 2018.  
The process from recruitment to the completion of the data collection took approximately 
four months.  Participants communicated with me via e-mail to consent to study 
participants and to schedule interview times.  I conducted the interviews by phone. All 
the participants engaged in the interviews from their homes.  At the beginning of each 
interview I explained to the participant that the interview would be recorded and the 
information given would be kept confidential. I asked that during the interview each 
participant be separated from the other participant to help secure the honesty of the 
answers. However, four participants out of the 16 needed to be near their family member 
in the study due to hearing difficulties. All 16 participants voluntarily agreed to be 
interviewed and recorded using a digital recorder.   
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The interview instrument consisted of six open-ended questions for the eight 
AAT-D participants and nine open-ended questions for the primary family caregivers.  I 
digitally recorded all 16 interviews, and the participants answered their questions in a 
session between 30 to 45 minutes.  The interview duration was based upon the amount of 
detailed information was provided.  A notebook was kept by my side where I made notes 
as cues to follow-up with additional questions and clarifications.  Follow-up questions 
were used to address the research questions and to collect further data regarding the 
participants lived experiences with AAT-D.  All 16 interviews were completed in its 
entirely the first time.  At the end of each interview, I thanked the participants for 
participating in my study.  I transcribed and coded each digital recording. The hard copies 
of the transcriptions and the written notes have been stored in a locked filing cabinet.   
Data Analysis 
I used a phenomenological method for this study and kept the focus on the 
phenomenon of the alpha-1 deficient participant and their primary caregiver’s coping 
mechanisms and the lived experiences identified by each participant.  For data analysis, I 
used the eight interview transcripts for the AAT-D and eight interview transcripts for the 
caregivers, which were then typed into a typed Microsoft Word table.  Each interview 
response to the questions were read multiple times to formulate codes, emergent themes, 
and sub-themes.  The table was helpful to me in methodically developing codes one at a 
time.  I developed a legend at the bottom of each table explaining the symbol and color 
highlight and what theme they represented.  
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To formulate the codes, I highlighted partial comments associated with each 
interview question and labeled “C1” in parentheses to indicate as code 1. Each interview 
question included diary notes, which I placed on the table and highlighted in the same 
color to the matching code as an identifier.  The same color highlight diary note would 
follow the partial comment which were included in the coding formulation.  I performed 
a thematic analysis to obtain the emergent themes by reading and re-reading the 
identified codes for each of the interview questions for both the alpha-1 deficient 
participants and the primary caregivers.  Validation for commonality between the four 
research questions was conducted and a careful analysis showed eight common themes 
associated with the four research questions.  For example, five themes (shock, lack of 
awareness from the healthcare community and patient, misdiagnosis, took an average of 
five to seven years to properly get treated, and physical limitations) emerged in answers 
to RQ1.  Themes for RQ2 had one similarity identified in RQ1 with an added aspect from 
the caregiver’s perspective (shock and despair to see their loved one struggle).  Finally, 
themes for RQ3 and RQ4 were the same (Keeping busy and family).   
To determine an in-depth meaning of the themes, I referenced the constructs of 
the Biopsychosocial Theoretical Model, Bowen’s Family Systems Theory, and the 
Family Systems Model of Illness (Engel, 1977; Bowen, 1974; Rolland, Emmanuel & 
Torke, 2017).  In the Results section, I present the results, the themes developed along 
with the support from the participants’ statements, and any detailed variances.   
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Triangulation 
 I achieved triangulation by asking each participant the same interview questions 
which allowed me to build a cohesive justification of themes (Creswell, 2014).  I 
developed Microsoft Word tables for each interview question to sort the data and 
discover the most common themes.  The identified common themes came from the 
participant’s responses to the administered questions.  The responses were analyzed for 
similarities and differences which helped to decrease bias.  Moreover, the use of rich and 
thick descriptions from the shared experiences of the AAT-D and their caregiver helped 
to increase the validity of my study.   
Evidence of Trustworthiness 
 The research findings for this qualitative study were verified to ensure the 
credibility, transferability, dependability, and confirmability.  Morse, Barnett, Mayan, 
Olson, and Spiers (2002), posit that the use of verification strategies helps to ensure the 
reliability and validity within a qualitative study.  This section presents the steps taken to 
demonstrate the evidence of trustworthiness.  Ensuring the validity in my study, I 
discovered the most common and beneficial coping mechanisms used across both the 
AAT-D participant and their primary caregiver that helped manage their stressors most 
optimally on a daily basis.  In addition, I used detailed descriptions of the shared 
experiences from the challenges between the AAT-D participants and their caregiver 
which helped to convey the results in a realistic manner.  Moreover, the dependability 
and confirmability were accomplished through audit trails.  For example, along with the 
verbatim transcripts, I kept detailed written information about the conducted study, 
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surrounding environment, whom I met with, and the degree of the explained results from 
the collected data helped to decrease the level of biased research, increasing the 
connection between the findings and the focus of the study. 
Results 
 The study findings are presented in this following section where I address the four 
research questions:  
 RQ1:  How do AAT-D patients describe living with their illness? 
RQ2:  How do the family caregivers who live with AAT-D patients describe their    
experiences? 
RQ3:  What are the common coping strategies among AAT-D patients? 
RQ4:  What are the common coping strategies among the family caregivers? 
 Data was collected from eight alpha-1 deficient participants and eight primary 
caregivers.  In this section, there are eight emergent themes that I present, along with 
examples from participants.  All the names of the participants associated with the quotes 
used within the study are kept confidential.  The research questions were created to 
examine the experiences of being an Alpha-1 patient and a family caregiver for someone 
living with Alpha-1 deficiency, as well as the coping strategies used on a daily basis.  All 
interviews were conducted from the privacy of their homes through the telephone and the 
participant’s consent was acquired before the interview.  The interview instrument 
consisted of six questions for the alpha-1 participants and nine for the primary caregivers 
that addressed the four research questions.  Each participant’s responses were coded to 
exhibit the relevant information.   
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The interview responses to question 1 for the alpha-1 participants addressed the 
date of their diagnosis, how long it took to be properly diagnosed, the challenges they 
may have experienced, and their overall perception of their diagnosis.  The interview 
responses to question 2 addressed if there has been any individual or group counseling.  
The interview responses to question 3 addressed how they cope with their disease, such 
as meditation, prayer, family.  The interview responses to question 4 addressed how they 
managed all the household duties and finances.  The interview responses to question 5 
addressed was what their overall experience living with alpha-1 has been.  The interview 
responses to question 6 addressed was how they thought their primary caregiver was 
managing their illness.  The interview questions 1, 4, and 5 addressed RQ1.  The 
interview responses to questions 3 and 6 addressed RQ2 and RQ3.  The interview 
responses to question 1 for the caregivers addressed their connection to the alpha-1 
participant.  The interview responses to question 2 addressed the challenges and positive 
aspects of being the primary caregiver.   
The interview responses to question 3 addressed their experience of their family 
member being diagnosed with alpha-1 deficiency.  The interview responses to question 4 
addressed their experience as the caregiver.  The interview responses to question 5 
addressed the responsibilities of the household duties and finances.  The interview 
responses to question 6 addressed if they have been to any individual or group 
counseling.  The interview responses to question 7 addressed how they are feeling 
physically and psychologically.  The interview responses to question 8 addressed how 
they cope with being the primary caregiver.  The interview responses to question 9 
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addressed how they think their alpha-1 family member is managing their illness.  The 
interview questions 1, 2, 3, 4, 5, 6, and 7 addresses RQ2.  The interview questions 8 and 
9 addresses RQ4.   
RQ1.  The first research question was:  How do AAT-D patients describe living 
with their illness?  I present the five themes that emerged from the participants’ 
responses about how AAT-D patients describe living with their illness.   
Theme 1: Shock 
 The first theme that emerged from RQ1 was: “shock.”  The one response that was 
common among the eight AAT-D participants was that they have never heard of such a 
disease and was surprised at the debilitating nature of the illness.  Excerpts from the 
participants’ responses to support this theme are presented below. 
 One participant, AAT-D 1 (male), noted “I was never sick before and then all of 
sudden I started getting consistent bouts of bronchitis…when I was diagnosed it was 
shock.”  AAT-5 (Female), commented, “You know my diagnosis was funny…I was 
never sick in my life until I turned 50 and was constantly sick…my diagnosis came as a 
shock.”  AAT-D 9 (Female), stated “It was when I was just turning 50…it came to me as 
a shock.”  AAT-D 15 (Male), described “…yeah it came to me as a complete shock.”   
Theme 2: Lack of Awareness 
 The second theme that emerged for RQ1 was:  Lack of awareness of the disease 
from both the healthcare community and AAT-D patient.  The participants shared their 
experiences on how the healthcare community was unaware of the disease and how to 
manage it.  Alpha-1 deficiency appeared to be an unheard of illness.   
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 One participant AAT-D 5 (Female), reported:  
The Radiologist suggested that in her whole time of practice no patient came 
back with a positive alpha-1 test…she had absolutely no information for me no 
direction, no brochures, no recommendations for a pulmonologist. She said was 
don’t drink or smoke because I have never seen this.  
AAT-D 7 (Female), commented “my doctor was very sad and upset and he could 
not find any literature on it…only that it was a fatal genetic lung disease…he said that he 
would try to find out about this disease.”   
AAT-D 11(Female), explained: 
I was getting foot surgery because of a fall but I could not shake the bronchitis, so 
the foot surgeon ordered a chest x-ray which revealed that I had COPD but I was 
too young to be diagnosed with that…so I did my research and brought it back to 
my primary physician and that is when he tested me for alpha-1 deficiency. 
Theme 3: Misdiagnosis 
 The third theme that emerged from RQ1 was: misdiagnosis.  The most common 
response from the eight AAT-D participants was that they were initially diagnosed with 
COPD/ Emphysema.   
AAT-D 3(Male) stated: I was surprisingly diagnosed with Emphysema with 
approximately half my lung function gone and I have never been a smoker… the 
PA asked the doctor did you check him for alpha-1?... the doctor leafed through 
my file and no joke said umm oops. 
AAT-D 5 (Male) explained: 
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…so we went to the doctor and they first thought I had RA…I just kept getting 
sicker and sicker and sicker…I stopped at the Mayo Clinic in Jacksonville and 
they ran a bunch of tests but did not run an alpha-1 test…they found I also had 
granulomatosis…however I was still short of breath and the doctors could not 
understand why I was short of breath…I then got sent to a gastroenterologist 
because my liver enzymes were high and they did not know why…it was there 
that they ran an alpha1 test which came back positive. 
AAT-D 7 (Female) declared: 
I decided to see an allergy specialist because I was so sick all the time… all my 
life I was told that I had asthma… I went to see a new doctor and he had just got 
back from a conference that talked about a rare disease called Alpha-1 deficiency 
and he said that I looked like I was going to die so he decided to run an alpha-1 
test… he looked sad and very upset and told me that there was no literature about 
this disease but only one article which said that it was a fatal genetic lung 
disease… he said he would do his best to find out more about it… 
AAT-D 11(Female) commented:  
…I had bronchitis that I just could not shake…I was ordered a chest X-ray to be 
safe and that is when it said I had severe COPD. So my primary doctor told me 
that it is important to not smoke and how we needed to find out more about why 
my lungs are so bad…well I went home to look up an old reference Mayo Clinic 
guide from 1981 and that is where it said in a small paragraph under emphysema 
that adults ages 30-50 can have early onset emphysema due to alpha-1 
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deficiency…so I brought this information back to my doctor where they tested me 
for it and sure enough that was what was going on… 
AAT-D 13 (Female) explained: 
I had going through a few bouts of being misdiagnosed with bronchitis and so 
forth… I was 36 years old at the time and they told me I had COPD but in my 30s 
that did not explain anything to me at the time and just sent me to a 
pulmonologist… he did a test right off the bat and called me in and said that I 
have alpha-1 deficiency… 
Theme 4: Lengthy Diagnosis Process 
 The fourth theme that emerged from RQ1 was: time of diagnosis was lengthy.  
The most common responses among the AAT-D participants was how it was a lengthy 
process to be appropriately diagnosed.  AAT-D 1 (Male) declared “it took about two 
years to be properly diagnosed.” AAT-D -3 (Male) suggested “it took about a year to be 
properly diagnosed.”  AAT-D 5(Male) claimed “…if they would have ran the test back in 
2010 instead of 2014 I would have had more lung function…” AAT-D 7 (Female) 
commented “…it took him a whole year to get properly diagnosed.” AAT-D 11(Female) 
said “…from the initial symptoms to get properly diagnosed was 17 years…” AAT-D 13 
(Female) exclaimed “…it took a couple of years to be properly diagnosed…” AAT-D 15 
(Male) declared “…oh gosh it took approximately five years to get properly 
diagnosed…” 
RQ2.  The second research question was:  How do the family caregivers who live 
with AAT-D patients describe their experiences?  I present one similar theme to RQ1 
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with an added aspect from the caregiver’s perspective.  The most common responses 
from the caregivers were shock and despair from watching their loved ones struggle.   
Theme 5: Shock 
 The two themes that emerged for RQ2 was caregiver shock and despair in 
watching their family struggle with the disease.  The participants shared their experiences 
they had in the initial diagnosis of their spouse and how it is a challenge to watch them 
struggle with the disease on a daily basis.  Caregiver 2 (Female) commented “It was a 
shock obviously…”  Caregiver 8 (male) stated “When she was initially diagnosed with it, 
I had never heard of it…” Caregiver 10 (Male) suggested “was a surprise.” Caregiver 12 
(Male) declared “…I don’t know anything about oxygen and I never have even heard of 
it…”  Caregiver 14 (Male) stated “Never heard of it before”. Caregiver 16 (Female) 
claimed “I never heard of it before.”  
Theme 6: Despair 
 Theme six that emerged for RQ2 was despair watching their loved one go through 
the challenges of living with Alpha-1 deficiency on a daily basis.  Caregiver 2 (Female) 
stated “…I have my responsibilities to do and I just do it. I love him When you are 
married for that many years, he is your buddy and I love.”   
Caregiver 4 (Female) explained: 
Well it is horrible and our life stopped. We have no life at all. We can’t travel or 
do anything physical. We have become more or less homebodies and I hate it with 
every ounce of my being but I have no choice and I have been married to him for 
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42 years…it’s a horrible disease and it is horrible to watch someone go through it 
and it’s horrible being a part of it and all the things he has to do to stay alive…   
Caregiver 8 (Male) stated “…there is a lot I help her with…it makes me feel 
better if I am able to be of assistance to her…”  
Caregiver 12 (Male) declared: 
The challengers about being a caregiver.  Um, with three kids probably trying to 
keep your wits together. Because it’s another strain on me just to go and get the 
remote of the entertainment center instead of her getting up to get it. She needs 
me to get it, I have normal lungs. Just the little small things you know, it’s 
definitely that middle challenge, by the end of the day when I’m tired and 
aggravated, not so much for the person, but for yourself, knowing that I’m tired 
and she needs that I’ll get it or if the kids need something I’ll get it, you know… 
Theme 7: Keeping Busy 
 Theme seven, keeping busy emerged for both RQ3 and RQ4.  The caregiver 
participants shared their experiences how maintaining a busy schedule is a way to cope 
with the illness.  The majority of the participants’ responses to coping was attempting to 
maintain a busy lifestyle through work and/or activities.  AAT-D 5 (Female) stated 
“keeping busy.”  AAT-D 7 (Female) commented “I like to stay real busy. I like to swim 
and work is so busy…Yeah I try to stay real busy so I do not think about it.”  AAT-D 9 
(Female) explained “I am trying to just live a normal life like not try to make that the 
center of everything try to go places and do things…”  AAT-D 13 (Female) suggested “I 
work as much as possible and stay on the go.”  AAT-D 15 (Male) declared “My farm, I 
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raise cattle for beef.”  Caregiver 4 (Female) noted I just do what I have to do…”  
Caregiver 8 (Male) commented “I have a number of projects that I am working on, 
welding, carpentry, stuff life that I manage to fill my days.”  Caregiver10 (Male) 
explained I do walk…I walk every day for about 2 miles with a couple of friends and we 
have a good time…I ride my Harley…”  Caregiver 12 (Male) suggested “I have some 
hobbies, golf is one of my releases…wood working…and yard work…” 
Theme 8: Family 
 Theme eight, family emerged for both RQ3 and RQ4.  The participants shared 
their experiences on how family helps them coping with the illness on a daily basis.  
AAT-1 (Male) stated “My wife has probably been the key to my coping. She has been 
phenomenal, and we have been married for 58 years…”  AAT-D 11 (Female) explained 
“…what motivates me the most is the kids. Having young kids at home and wanting to be 
around for them…”  Caregiver 2 (Female) declared “…we do everything together…you 
cope and move forward.”  Caregiver 6 (Male) suggested “…she is my wife and that is all 
I need…do not feel like I need to cope.” Caregiver 14 (Male) declared “No I just cope, as 
long as I get to hold her, I am just fine.” 
Summary 
The purpose of this study was to study the lived experiences of Alpha-1 deficient 
participants and their primary caregiver, as well as the coping mechanisms used by both 
the alpha-1 deficient participant and their family caregiver.  In chapter 4, I presented a 
review of the data collected and how the data was managed and analyzed.  The 16 
participants declared that they understood the Informed Consent before the start of the 
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interview.  The responses from the interviews examined the lived experiences of alpha-1 
participants and their primary family caregiver and how they coped with the illness on a 
daily basis.  A descriptive phenomenological method was used, and the appropriate steps 
were incorporated to ensure that the lived experience among the alpha-1 community was 
expressed accurately.  In response RQ1, most of alpha-1 participants commented how 
“shock” was the initial feeling to being diagnosed with the illness. They had never heard 
of the illness and were surprised at its debilitating nature.  Lack of awareness was another 
common response represented by both the alpha-1 participant and healthcare community.   
The participants shared their experiences on how the healthcare community was 
unaware of the disease and how to manage it.  Additionally, the majority of the alpha-1 
participants explained how they were initially misdiagnosed with COPD/Emphysema.  
Lastly, for RQ1 was the lengthy time for proper diagnosis.  The most common responses 
from the participants was how it took time and the correct tests to be appropriately 
diagnosed and placed on the correct plan of action.  Reponses to RQ2 revealed caregiver 
shock and despair in watching their loved one struggle with alpha-1 deficiency daily.  
The participants shared their experiences they had in the initial diagnosis of their spouse 
and how it is a challenge to watch them struggle with the disease.  Responses from the 
participants to RQ3 and RQ4 demonstrated that keeping busy and family helps the 
caregivers cope with the illness.   Chapter 5 presents the interpretation of the research 
findings, limitations, recommendations, social change implications, and conclusion.   
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of the present study was to examine the lived experiences of Alpha-1 
deficient patients and their family caregiver, as well as the coping mechanisms used by 
patients and caregivers.  I used the descriptive phenomenological method to gain a deeper 
insight into the shared experiences of the alpha-1 patients and their primary family 
caregiver.  Specifically, I used this method to gather individual perceptions from both the 
alpha-1 patient and their family caregiver, as well as shared perceptions regarding 
managing alpha-1 deficiency and the challenges participants have faced from the initial 
diagnosis to the present.   
In reviewing previous literature, I found a lack of information on the lived 
experiences of alpha-1 deficient patients and their family caregiver related to the coping 
mechanisms used to manage the stressors.  Previous researchers have mainly focused on 
the uncertainty and complexity of how COPD can be stressful for not only the patient but 
also the patient’s family caregiver (Stenzel et al., 2015).  Moreover, previous research has 
shown that the interaction between the COPD patient and the patient’s family caregiver 
affects how both parties cope with the disease’s physical and psychological demands 
(Barnett, 2004; de Voogd et al., 2011; Figuerido et al., 2014., Hoth et al., 2015).   
However, what is unknown, according to my review of the literature, is the 
complexity of AAT-D-associated COPD and the specific disease-related anxieties of both 
the alpha-1 deficient patient and the patient’s family caregiver, as well as the coping 
mechanisms used by both.  Thus, I conducted this study to better understand the lived 
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experiences of alpha-1 deficient patients and their family caregivers and how they 
manage their stressors daily.  I formulated four research questions to address the specific 
goals for this study: 
RQ1. How do AAT-D patients describe living with their illness? 
RQ2. How do the family caregivers who live with AAT-D patients describe their 
experiences? 
RQ3. What are the common coping strategies among AAT-D patients? 
RQ4. What are the common coping strategies among the family caregivers? 
I administered six interview questions to the eight alpha-1 deficient participants 
and nine interview questions to the eight primary family caregiver participants, several 
themes emerged from participants’ responses.  The key findings for RQ1 were that the 
alpha-1 deficient participants declared how shock, lack of awareness, misdiagnosis, and 
the process that it took to properly be diagnosed were all challenges they experienced.  
They reported that (a) they have never heard of such a debilitating illness before being 
diagnosed, (b) neither they nor the health care community were familiar with the disease, 
(c) they were initially diagnosed with COPD, and (d) being appropriately diagnosed and 
managed was a lengthy process.  The main findings for RQ2 were caregiver shock and 
despair in watching their family member struggle with the illness.  The key findings for 
RQ3 and RQ4 were coping by keeping busy and family.  The participants shared how 
maintaining a busy schedule and family support system were critical elements in coping 
with the challenges of alpha-1 deficiency.   
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Interpretation of the Findings 
Alpha-1 antitrypsin deficiency was discovered in 1963 by Laurell and Erisksson 
(Anariba, 2017) who found that five of the 1,500 serum protein electrophoreses (SPEP) 
submitted to their laboratory in Sweden had the absence of the band of alpha-1 protein.  
Moreover, Laurell and Eriksson discovered that three of the five patients were diagnosed 
with emphysema at a young age, leading them to develop the cardinal clinical features of 
AAT-deficiency with absence of the AAT and early onset emphysema (Anariba, 2017).  
For example, people whose bodies do not produce enough of the protein AAT are more 
likely to develop emphysema typically between 30-50 years old.  Physicians should 
suspect AAT-deficiency if the patient develops emphysema at 45 years of age or 
younger; develops emphysema without having any recognized risk factors, such as 
smoking or exposure to chemical fumes or pollutants over a long period of time; x-rays 
show less density in the lungs than normal; or the patient has unexplained liver disease, 
necrotizing panniculitis, bronchectasis without any cause, or asthma that does not 
completely resolve after the use of regular breathing treatments (Fahy et al.,  2014).   
COPD is an umbrella term used to describe progressive lung disease including 
emphysema, chronic bronchitis, asthma, and some forms of bronchiectasis (COPD 
Foundation, 2017).AAT-D is a relatively common genetic disorder that is often 
undiagnosed; people with AAT-D are predisposed to COPD and liver disease (Anariba, 
2017).  Some previous researchers studying  COPD have examined the interactions 
between family caregivers and their patients. For example, researchers have focused on 
the coping strategies, such as problem-solving strategies, emotional-cognitive strategies, 
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and stress management strategies, used by COPD patients and family caregivers (Barnett, 
2004; de Voogd et al., 2011; Figueirdo et al., 2014; Hoth et al., 2015) COPD patients’ 
experiences (Barnett, 2004; de Voogd et al., 2011; Figueirdo et al., 2014; Hoth et al., 
2015); how dyspnea in COPD patients may increase anxiety levels (Barnett, 2004; de 
Voogd et al., 2011; Figueirdo et al., 2014; Hoth et al., 2015); how the severity of the 
symptoms may impact alpha-1 patients’ quality of life (Barnett, 2004; de Voogd et al., 
2011; Figueirdo et al., 2014; Hoth et al., 2015); and how illness uncertainty may increase 
anxiety levels (Barnett, 2004; de Voogd et al., 2011; Figueirdo et al., 2014; Hoth et al., 
2015).  The results of the present study showed the complexities of alpha-1 deficiency 
and the challenges the alpha-1 community face daily.  My findings indicated that the 
alpha-1 deficient participants were previously unaware of the disease and were often 
misdiagnosed.  The time from the initial symptoms to the appropriate diagnosis proved to 
be a lengthy process.  Previous researchers have not reported these findings, according to 
my review of the literature.   
The results of this study showed that the both the alpha-1 patient and the patient’s 
primary caregiver used a variety of coping strategies to manage the stressors of the illness 
on a daily basis.  Coping strategies such as staying busy with hobbies and work and 
having  a supportive family dynamic were the key components in managing the stressors 
of alpha-1 deficiency for the majority of the participants in this study.  I identified eight 
themes from the participants’ answers regarding living with alpha-1 deficiency on a daily 
basis: shock, lack of awareness from both the Alpha-1 health care community and alpha-
1 deficient patients, misdiagnosis, lengthy diagnosis, caregiver shock, despair in watching 
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their loved ones struggle with the disease, as well as keeping busy and family 
relationships to help cope with the obstacles of alpha-1 deficiency on a daily basis.   
The eight alpha-1 deficient participants reported that they had never heard of the 
disease before being diagnosed with it and were surprised at the debilitating nature of the 
illness. Several of the alpha-1 deficient participants also mentioned that they were never 
sick until the abrupt symptoms, such as difficulty breathing while performing their 
normal activities or continuous bouts of bronchitis and pneumonia.  In addition, all eight 
of the alpha-1 deficient participants reported that their doctors or physician assistants 
stated that they were unaware of the disease and how to properly manage it.  Previous 
research has shown that there is a high rate of undetected or misdiagnosed AAT-D and 
that it takes an average of seven to eight years to be properly diagnosed (Campos et al., 
2005).  The present study confirmed those challenges of AAT-D with five out of the eight 
alpha-1 participants stating they were misdiagnosed with COPD, bronchitis, asthma, or 
some other illness.  The participants also reported that it took anywhere from a year to 12 
years to be properly diagnosed.  Previous researchers have examined the effect that the 
type and quality of a relationship has on the COPD participants’ overall psychological 
state; their research suggests that having more support from their partners helped to 
decrease patients’ stress levels while having less support resulted in  higher stress levels 
(DiNiCola et al., 2013).  In the current study I focused on AAT-D participants and found 
that all eight alpha-1 participants were managing their psychological stressors with the 
positive support from their family.   
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In the present study, seven out of the eight caregiver participants experienced 
shock when their spouse was diagnosed with alpha-1 deficiency.  Only one out of the 
eight caregiver participants was not surprised with the diagnosis because her husband’s 
brother was diagnosed earlier with the genetic illness. Prior related research has found 
that pervasive dyspnea can be frightening to both the patient and the caregiver which can 
lead to high stress levels (Lee et al., 2010).  The current study suggested that caregivers 
exhibited despair in watching their loved ones struggle with the disease. All eight 
participants stated that it is a terrible disease which makes it difficult for them to see their 
spouses manage the challenges of alpha-1 deficiency.  However, the degree of the alpha-
1 participants’ symptoms, how involved the caregivers were to their spouse, and the 
depth of their relationship with their spouse all played a role on how they managed their 
stressors.   
Previous research has shown that caregivers for COPD patients that observe their 
family member with COPD experiencing progressive dyspnea, physical disabilities, 
altered cognition, memory disturbances, and behavioral changes will further strain the 
family caregiver’s overall life (Lee et al., 2010). Caregiver burden is described as the 
distress that caregivers feel as the result of providing care which is specific to the 
complexity and degree of the disease care (Rha et al., 2015).  However, the present study 
found that seven out of the eight caregivers did not feel like it was a challenge to take 
care of their spouses.  They expressed that is a natural aspect to take care of the spouse.  
Several of the participants were married for more than 20 years.  Only one out of the 
eight participants found every aspect of the disease while taking care of their spouse a 
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horrible experience and if she would have known her spouse would be as sick prior to 
marriage, she would have never married him.   
The biopsychosocial model (Engel, 1977) was used in the present study to 
examine how experienced biological factors, such as genetics and dyspnea could be the 
possible reason for the anxiety and uncertainty levels of the participants. All eight of the 
alpha-1 participants reported that they have and continue to feel anxious when their 
breathing difficulty levels increase. Fifteen out of the 16 participants felt anxious during 
the initial diagnosis because of the unknown genetic characteristics of the disease.  
Previous research has shown that the perceived uncertainty about the current symptoms 
and future prognosis is the challenging part of living with a chronic illness.  Hoth et al. 
(2015) analyzed illness uncertainty, such as ambiguity (physical symptoms) and 
complexity (treatment and healthcare system) among alpha-1 deficient associated COPD 
patients and found that uncertainty about physical symptoms (ambiguity) induced 
depression, anxiety, breathlessness while decreasing alpha-1 deficient patients’ quality of 
life.  
In the present study, only one out of the eight couples did not feel anxious during 
the diagnosis because of the known properties of the illness from prior family 
experiences.  The current study found that keeping a busy schedule, such as working 
within the alpha-1 community and hobbies helped the 15 out of 16 participants to cope 
with the stressors in their daily lives.  The Bowen Family Systems Theory (2017) and the 
Family System of Illness (Rolland et al., 2017) were used in the current study which 
showed that the strength of the family interaction was an intricate part in how both the 
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alpha-1 deficient and caregiver participants coped with the illness.  Fifteen out of 16 
participants suggested that it was the family unit that kept them going in life.   
Limitations of the Study 
 I intended to recruit eight alpha-1 deficient participants who were diagnosed with 
alpha-1 deficiency that did not currently smoke and eight primary family caregivers who 
lived in the southern portion of the United States through a mass email sent out to the 
alpha-1 community describing my study from the Alpha-1 community’s associative 
director.  The total process time for recruiting participants was approximately four 
months and at the half-way point I placed a reminder email for the associative director of 
the Alpha-1 community about the study.   
A limitation of the study was three out the eight couples could hear each other’s 
interview questions because of hearing difficulties which may have caused them to 
withhold their true answers to the interview questions.  Another limitation was that the 
participants were from different geographic areas which may have provided a variety of 
perceptive experiences.  Although the study had a few limitations, the background 
information, framework of the study, as well as the detailed description of the study may 
be used to further investigate and compare future studies using the same populations.   
Recommendations 
 The present study increased the understanding of the lived experiences and coping 
mechanisms of alpha-1 deficient and their primary caregivers. However, future research 
may further investigate the effects for the patient and the caregiver of participating in a 
support group. Does the support group reduce feelings of burden on the caregiver? It also 
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may provide a normalizing effect for both caregiver and patient.  Another 
recommendation would be to examine the siblings who are not considered an alpha and 
how it plays a role in their psychological state on a daily basis.  In particular, the future 
study could analyze if they have “survivor guilt” and the aspects that impact their lives.  I 
also recommend conducting a study on the depth of alpha-1 awareness across the 
healthcare community and how it can be improved.  How can the alpha-1 community 
bring more education and awareness to the healthcare personnel in order to achieve a 
quicker and more accurate diagnosis? Another recommendation is to examine how AAT-
D patients identify with the disease.  Does the illness identify them?  In addition, does 
gender play a role in how AAT-D patients manage their stressors or is there a biological 
aspect that exposes differences in the degree of physical and/or psychological symptoms? 
Implications 
 Many opportunities exist to make a positive change across the alpha-1 
community.  The findings from the current study can positively add to the current body of 
literature used to understand the lived experiences of alpha-1 deficient participants and 
their primary caregiver, as well as their coping mechanisms.  It was apparent that shock, 
lack of awareness, misdiagnosis, and the lengthy time of diagnosis proved to be a few of 
the challenges among the alpha-1 deficient participants and caregiver shock.  
Additionally, despair in watching their loved ones struggle on a daily basis was a central 
issue from the caregivers.  However, maintaining a busy schedule and engaging in a 
positive family environment showed to be positive coping mechanisms for both the 
alpha-1 deficient participants and their caregivers.   
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Conclusion 
 The present descriptive phenomenological study focused on the phenomenon of 
alpha-1 deficiency and investigated the lived experiences of the alpha-1 deficient 
participants and their caregivers, as well as their coping mechanisms.  The experiences of 
the alpha-1 deficient participants and their caregivers were expressed through recorded 
phone interviews and provided accurate descriptions that established significant themes 
that led to a better understanding of the phenomenon of alpha-1 deficient participants and 
their primary caregivers while gaining a deeper insight into the coping mechanism used.   
 The current study extends the previous knowledge of the lived experiences of 
alpha-1 deficient participants and their primary caregivers, as well as the coping 
strategies used.  As a result of this study, the phenomenon of the complexities of alpha-1 
deficiency and the life experiences of alpha-1 deficient participants and their caregivers 
were shown to be challenges.  However, being active within the alpha-1 community, 
engaging in hobbies, and having a supportive family dynamic proved to be positive 
aspects in coping with the stressors.   
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Appendix A: Letter Sent to Participant 
        Date 
Name of Participant 
Address 
 
Dear (Name), 
 
My name is Nicolette Bruscino and I am a doctoral candidate at Walden University.  I am 
conducting dissertation research on the complexity and challenges AAT-D places on both 
the AAT-D individual and their family caregiver, as well as the coping mechanisms used 
from both the AAT-D individual and their family caregiver on a daily basis. There are a 
vast number of studies detailing the difficulties of COPD and how to better manage the 
illness, as well as the obstacles faced on the primary caregiver to COPD individuals.  
What is not known, however, are the specific challenges of AAT-D associated COPD 
individuals and their family caregivers, as well as the most optimum coping strategies 
used to better manage the stressors from both the AAT-D individual and their family 
caregiver on a daily basis. 
 
I realize that your time is important to you and I appreciate your consideration to 
participate in this study.  In order to understand your experience we need to meet for one 
interview for approximately one hour. The interview can be held at a location of your 
choosing and will not require you to do anything you don’t feel comfortable doing.  The 
interview is designed to simply get to know you and learn about your experience of being 
an AAT-D individual or the sole family caregiver of the AAT-D individual.  All 
information gathered during our interview will be kept strictly confidential.   
 
Please contact me at your earliest convenience to schedule a date and time that we can 
meet.  My telephone number is XXX.  You can also email me at XXX.  I look forward to 
hearing from you. 
 
Nicolette Bruscino 
Doctoral Candidate 
Walden University    
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Appendix B: Interview Questions AAT-D Participants 
1. Tell me about your diagnosis.  
A. When was the date of your diagnosis? 
B. How long did it take to get properly diagnosed? 
C. Where there any challenges of being diagnosed? 
D. What is your personal outlook on your diagnosis? 
2. Tell me about any individual or group counseling you have had. 
3. How do you cope with your disease? For example, some people use distractions, 
prayer, or meditation.? 
4. How do you manage all the household duties and finances? 
5. What has been your experience living with AAT-D? 
Family Caregivers 
1. What is your connection to the AAT-D participant? Are you the primary 
caregiver? 
2. Tell me about the challenges of being a caregiver. What are the positive aspects of 
being a caregiver? 
3. Tell me about your experience about your family member being diagnosed with 
AAT-D. 
4. Tell me about your experience as a caregiver. 
5. Tell me about the responsibilities of the household duties and finances. 
6. Tell me about any individual or group counseling you have had. 
7. Tell me how you are feeling physically and psychologically. 
8. How do you cope being the primary caregiver? 
